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CHAPTER I
INTRODUCTION
The inflammatory response is a complex interdependent seQuence
of local vascular, cellular and tissue events that launch reparative
processes at the host's damaged tissue.

The acute inflammatory re-

sponse is heralded by vascular dilatation and marked alterations in
vascular permeability leading to the exudation of protein and cellular
elements at the inflammatory site.

The

macrophage~

i.e. the mono-

nuclear phagocyte, and polymorphonuclear leukocyte (PMNL) constitute
the two major phagocytic cell populations that accumulate at the
site of tissue injury . . The cellular development of the local inflammatory reaction classically features an early infiltration by the
PMNL which is subseQuently replaced by the inflammatory macrophage as
the principal phagocytic mediator of the host's defense reactions
(105 ).

Macrophages and PMNL

at the inflammatory locus perform the

vital functions of clearance, degradation and detoxification of invading foreign organisms and cellular debris by employing endocytic
and intracellular digestive mechanisms.

However, the homeostatic con-

trol mechanisms and cellular interactions influencing the metabolic
demands among inflammatory cell populations are poorly understood.
The maintenance of PMNL and macrophage function is ultimately contingent upon
energy.

t~e

continual provision of substrate supply and cellular

The relative importance of glycolytic and oxidative pathways
l
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as energy sources varies markedly among the different macrophage and
PMNL populations ( 85 ).

Early in vitro studies centering on macro-

phage metabolism focused attention on metabolic alterations subsequent
to phagocytosis (66).

Glycolysis and respiration were transiently

stimulated during the phagocytic event in macrophages, however certain
macrophage populations are capable of deriving their energy for phagocytosis exclusively from glycolysis under anaerobic conditions either
in vitro or at the inflammatory site where low oxygen tensions prevail.
Macrophage endocytic capacities include both phagocytosis and
pinocytosis - terms utilized to describe the cellular ingestion of
particulate matter and soluble components of their external environment, respectively.

In addition to its role in microbial host defense,

endocytosis affords a mechanism whereby the inflammatory macrophage
enriches its fuel supply by ingestion and degradation of macromolecules
found at the inflammatory site.

Glycogen, an important carbohydrate

fuel reserve, is one such macromolecule which is found in abundance in
the PMNL (109). Histological studies have provided evidence that the
glycogen-laden PMNL shedscytoplasmic fragments during the early course
of the inflammatory response while the macrophage rapidly engulfs this
potential source of fuel molecules (141).
Although glycogen content and the mechanisms responsible for
glycogen synthesis and degradation have been extensively investigated
in various leukocyte populations, glycogen content and its regulation
within macrophages have not received similar quantitative attention.
Thus the intents of this study are to evaluate in vitro the physiological responses of macrophages to exogenously added glycogen and to

3

assess glycogen metabolism and those control mechanisms responsible for
glycogen synthesis and utilization within the macrophage derived from
the inflammatory locus.

\

CHAPTER II
HISTORICAL REVIEW
A.

The Role of the Macrophage in Inflammation
1.

His·torical development and knowledge of the macrophage
system

Although it was known that different forms of leukocytes occurred in blood was in evidence as early as 1865.(108), the early
functional history of the mononuclear phagocyte pivots around the exhaustive studies of Metchnikoff (82).

In a series of comparative

studies concerned with the cellular response following tissue injury,
Metchnikoff investigated the phagocytic activity of inflammatory cells
derived from both invertebrate and vertebrate species.

He demonstrated

the ultimate dominance of the phagocyte in the defense reactions of
the host to inflammatory stimuli.

Furthermore, he also was the first

to distinguish between the macrophage, i.e., big eater, and the microphage, the smaller polymorphonuclear leukocyte.

In the following dec-

ade, Goldman (49) and others employed vital staining techniques and
illustrated the ubiquitous occurrence and organ localization of mononuclear phagocytes.

As an outcome of these early histological studies

Aschoff (3) coined the term reticuloendothelial system (RES) to describe the concept of a widely distributed collection of mononuclear
phagocytes which are united by similar morphological and functional
properties and potentialities.

The RES includes both the fixed

macrophage populations localized primarily in the blood
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sinuses of the liver, lung, spleen, and bone marrow

an~

the mobile mac-

rophage pool found in the serous cavities of the organism.

Thus fol-

lowing Aschoff's formulation of the RES concept as a phagocytic
functional system and metabolic apparatus involved in host defense
mechanisms, all subsequent investigations have resulted in determining
the potential and multiple roles of the mononuclear phagocyte in physiological and pathophysiological settings.
2.

Origin of the inflammatory macrophage

The origin and identity of the precursor cell which gives rise
to the macrophage of the inflammatory exudate have been studied and
debated for more than thirty years.

Ebert and Florey (39) using rabbit

ear chambers observed that monocytes infiltrated from the peripheral
blood into the inflammatory site and differentiated into macrophages.
However, it was argued by Rebuck and his colleagues (96, 98) that
inflammatory macrophages were derived primarily from lymphocytes.
Rebuck utilized the "skin window" technique in which glass coverslips
were applied to areas of abraded human skin and then periodically
removed and examined microscopically.

It was concluded from these

studies that small lymphocytes evolved through a series of intermediate
cell types into inflammatory macrophages.
Recent in vivo and in vitro labelling studies have supported
the conclusions that under physiological conditions and during the
acute inflammatory response, the inflammatory macrophage is principally
derived from peripheral blood monocytes.

That mononuclear phagocytes

ultimately originated from bone marrow precursors was first demonstrated
by Balner (5) in radiation chimeras give~ allogenic bone marrow cells.
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Both transfusion studies with 3H-thymidine labelled bone marrow cells
into syngenic rats (129) and labelling studies in X-irradiated animals
with shielding of the bone marrow (126) have provided direct evidence
not only for the existence of monocyte precursors in the bone marrow
but also that the peritoneal macrophage population is derived from
blood monocytes.
Induction of

an inflammatory response in the peritoneal cavity

of mice resulted in a two- to threefold increase in the number of peritoneal macrophages by 72 hours following the introduction of an irritant (19).

In vitro incubation of these

periton~al

macrophages in

the presence of 3H-thymidine indicated a labelling index comparable to
peritoneal macrophages from unstimulated animals, suggesting that the
increase in macrophage population as a result of the inflammatory
stimuli is not the result of increased mitotic activity (126).

How-

ever, when peripheral blood monocytes were labelled in vivo with repeated injections of 3H-thymidine and a peritoneal inflammatory response was induced, these experiments resulted in a 45 to 65% increase
in the labelling of inflammatory peritoneal macrophages.

Thus these

experiments add overwhelming evidence in favor of the blood monocyte
origin of the inflammatory macrophage.
3.

Morphology and maturation of the inflammatory macrophage

Maximow and Bloom (80) provided the first detailed account
of macrophage morphology and distinguished macrophages from the blood
lymphocyte by their "active amoeboid protoplasm" and inclusion bodies.
Macrophages are large (20-40~ cells having an eccentrically located
horseshoe-shaped nucleus with an azurophilic granular cytoplasm
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containing numerous dense bodies and mitochondria (17).

An extensive

Golgi apparatus occupies the perinuclear area with lysosomal-like
granules and mitochondria located at the periphery of the Golgi zone.
At the light microscope level, the macrophage cell membrane is characterized by a ruffled appearance.

When macrophages are allowed to ad-

here to a glas·s surface, the cell membrane becomes dramatically well
spread out and intensely ruffled (46).
Recently, the ultrastructure of the peritoneal macrophage has
been under intense investigation (13, 22, 37) and has revealed a complex cytoplasmic structure and many prominent cell membrane processes.
The macrophage membrane surface is studded with spherical indentations
O.~in

diameter suggesting ongoing active pinocytic vacuole formation.

A granular endoplasmic reticulum and Golgi apparatus are well developed
and have been shown to be the site of formation of the primary lysosome.
In the mature macrophage many smooth surfaced vesicles (50-100 nm in
diameter), the primary lysosomes, are distributed throughout the Golgi
zone.

The most prominent cytoplasmic inclusions are the large number

of electron-dense granules demonstrated to be lysosomal in character
by their positive acid phosphatase reaction (14).

Such heterogeneous

granules are seen to contain varying amounts of lipid or dense staining
material and are clearly secondary lysosomes.

Labelled marker par-

ticles have been demonstrated to be incorporated within these lysosomal
structures by combination with phagocytic or pinocytic vacuoles formed
at the membrane surface (16).
Peritoneal macrophages in culture have been extensively used
to study the maturation process of monocyte to macrophage differentiation.
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Lewis (77) first observed, by culturing mixed blood cells, that blood
monocytes altered their morphological appearance and matured into large
macrophages, epithelioid and giant cells.

More recent studies have con-

cluded that the induction of macrophage maturation by in vitro culturing
techniques or in vivo, by lipopolysaccharide stimulated animals, resulted
in similar morphological and biochemical alterations (19, 21).

It was

demonstrated by these authors that mouse peritoneal cells underwent a
temporal sequence of morphological alterations including an increase in
the number of phase-dense, acid phosphatase-positive granules and mitochondria.

In addition, the size of the Golgi apparatus was markedly

increased as well as the number of large lipid inclusions that were
associated with the rough endoplasmic reticulum.

Thus it is apparent

that the arrival of the blood monocyte to the inflammatory site alters
the macrophage into a large cell with more digestive capacity and
phagocytic potential resulting in a dramatic stimulation in the
functional properties of the inflammatory macrophage.

4.

Migration behavior of the macrophage

Subsequent to all injury, alterations occur in the immediate vasculature and local tissue milieu leading to the emigration of phagocytic
cells and the extravasation of plasma constituents.

Although the PMNL

is the preponderant cell type mobilized during the initial stage of the
inflammatory reaction, within 24 hours, macrophages infiltrate the inflamed area and develop into the dominant phagocytic cell (105).

The

mechanisms underlying this temporal sequence and the eventual localization of the macrophage are poorly understood.

Difference in PMNL

and macrophage migration rates have been postulated as to why these t1vo
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cell types do not appear simultaneously during the developing inflammatory reaction (138).
chemotaxis, the directional movement of cells toward a chemical
substance, has been the in vitro approach utilized to study the mechanism
of phagocytic cell migration (54, 81).

The chemotactic effect of a

variety of substances is thought to be due to the formation of mediators
(cytotaxins) produced by the interaction of these substances with normal
plasma or serum (117).

Several authors have suggested that there is no

striking difference in the chemotactic response in vitro of macrophages
l

and PMNL (54, 69).

However, Ward (133) has recently reported several

chemotactic factors specific for mononuclear cells.

One of these fac-

tors was derived from PMNL lysates indicating a functional relationship
between these two cell's migratory behavior.

Furthermore, the absence

of circulating neutrophils has been reported to markedly reduce the
appearance of mononuclear cells in experimentally induced inflammatory
reactions (87).
Other chemotactic factors to which mononuclear cells respond inelude a factor generated in serum by interaction with antigen-antibody
complex, fragmentation products of the third and fifth components of
complement, and soluble bacterial factors.

The interaction of lympho-

cytes derived from animals exhibiting delayed hypersensitivity reactions
wit~

specific antigen produces a material, migration inhibiting factor,

inhibiting the random motion of normal macrophages in vitro (30).
From these studies, it is obvious that a variety of processes
at the inflammatory site generate soluble chemotactic factors whose
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activities can be demonstrated in vitro, however the relative importance
of the factors under in vivo conditions remains to be identified.

Al-

though the cellular energetics involved in macrophage migration has not
been adequately explored, recent information relative to the biochemical
events of how chemotactic agents organize cell movements has assigned
a major role in the mobility of phagocytes to contractile proteins and
a microtubular system which possesses divalent cation-sensitive ATPase
activity (119) ..

5.

Endocytosis and digestion by the macrophage

The physiological expression and functional classification of
the macrophage are ultimately dependent upon its ability to engulf material from the external environment.

This endocytic process encom-

passes both phagocytosis, the ingestion of particulate matter, and
pinocytosis, the ingestion of soluble components of the external medium.
The literature pertaining to phagocytosis is enormous and has been repeatedly reviewed ( 9, 17, 83, 84, 119).

Although pinocytosis was first

described over forty years ago ( 77), only recently has this endocytic
process been extensively examined and reviewed (17, 41).
a.

Phagocytosis:

Phagocytosis is a complex cellular phenomenon requiring on the
part of the macrophage the expenditure of energy and the interaction of
the particulate matter with certain properties of its limiting membrane.
Investigations into the mechanism of phagocytosis have classically divided the endocytic event into the following sequencerecognition and attachment, ingestion, and digestion of foreign material.
The macrophage displays selectivity in what will be phagocytized
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by recognizing certain characteristics on the surface of the material
to be ingested.

The importance of surface requirements for phago-

cytosis was first recognized by Wright and Douglas (140) who observed
that bacteria had to interact with unknown serum components, which
they named "opsonin", before phagocytosis would occur in vitro.

Recent

investigations· have identified certain immunoglobulins that are able
to bind selectively to the macrophage surface membrane (10).

These

antibodies cytophilic for macrophages have been identified as IgG
and represent the heat stable portion of hyperimmune serum opsonic
activity although other immunoglobulins can also bind to the macrophage surface (8).

A heat labile component of serum recently demon-

strated to express opsonic activity has been identified as the C3 component of the complement protein (65).

Although the mechanism by which

macrophages respond to an opsonic surface is not known, there is evidense that the Fe fragment of the IgG molecule attaches to the membrane
surface of the macrophage and somehow the cell recognizes a conformational change in the antibody molecule when it combines with the particular antigenic determinant (91).

The attachment of large particu-

late matter, i.e. red blood cells, to the macrophage surface has been
studied (93, 127) with the result that attachment of aldehyde-treated
red blood cells to the macrophage cell membrane is temperature dependent but independent of serum or cation, while the ingestion
process required the presence of both serum and cations in the medium.
Thus the coupling of macrophage receptor molecules with opsonized
'
particles may not only serve a recognition role but also function to
trigger the ingestion phase in some phagocytic systems.

Ingestion of
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particulate matter by phagocytic cells is an energy dependent process
initiating a complex sequence of morphological events.

Following

contact with the macrophage's cell surface, the particle is surrounded by the plasma membrane by pseudopodia which fuse at the distal side of the particle to form the phagocytic vacuole or phagosome.
As the phagosome· moves centripetally into the cytoplasm, primary
lysosomes interact and fuse with the phagosome (60), resulting in
the formation of a phagolysosome.

A network of microfilaments has

been observed in macrophage pseudopodia during ingestion and is
thought to be the intracellular contractile element involved in macrophage movement and membrane deformability (95).

Cohn and Wiener

(25) have investigated the intracellular events subsequent to ingestion and have demonstrated that acid hydrolyases are released from
the primary lysosomes and are redistributed about the newly-formed
phagocytic vacuole.

Thus the degranulation of the vacuole contents

involves the transfer of digestive enzymes from the lysosome ·converting
the phagocytic vacuole into a digestive organelle.
b.

Pinocytosis

Although both PMNL and macrophages actively engage in phagocytosis, of the two, only the macrophage is capable of pinocytic activity (84).

Pinocytosis serves as a mechanism whereby the macrophage

transports exogenous material into lysosomal granules.

Small invagi-

nations of the membrane surface form pinosomes which migrate inward and
fuse with Golgi residues containing newly synthetized acid hydrolases
forming secondary lysosomes.
~

Pinocytosis in peritoneal macrophages in

has been demonstrated to be regulated by medium constituents (24)
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and depressed by inhibitors of glycolytic or oxidative phosphorylation

(16).

The rate of pinocytic activity in vitro is significantly in-

creased by a variety of molecules: l) anionic molecules including albumin, acidic polysaccharides, RNA, and DNA and
as ATP.

2) nucleotides such

The presence of optimal concentrations of serum in the in-

cubation media not only stimulated pinocytic activity but also increased the number of lysosomes as well as the levels of acid

hydro~

lases, suggesting a direct correlation between serum concentrations,
pinocytosis, and enzyme accumulation.

Macrophage lysosomes contain

a variety of acid hydrolases that are capable of degrading macromolecules to low molecular weight products which then are excreted
or utilized by the cell.

Recent observations have been made on the

uptake and intracellular fate of soluble proteins by peritoneal
macrophages (40).

Iodinated human serum albumin was pinocytosized

and transferred into lysosomes where the protein was degraded and a
TCA-soluble isotope excreted.

These studies point out the probable

role of macrophage proteases and peptidases in digestion of foreign
protein with the concomitant return of TCA-soluble peptides or amino
acids to the extracellular environment.

The mechanisms of uptake,

storage and hydrolysis of carbohydrates were recently studied in the
mouse peritoneal macrophage (20 ).

Nonutilizable disaccharides were

pinocytized and formed large acid phosphatase-positive vacuoles in
the perinuclear region.

Monosaccharides with molecular weights up

to 220 did not produce lysosomal vacuolization.

Those oligosac-

charides which did produce vacuolization were shown to be resistant
to the complement of macrophage acid hydrolases and are quantitatively
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retained within the cell during the incubation period.

Thus at the in-

flammatory site the macrophage is capable of responding to a variety of
stimuli by displaying a state of heightened physiological activity.
This maturation process is accompanieq by profound alterations in
function and morphology which have been referred to as differentiation.
It is evident that the potential of macrophages to adapt and respond
to external stimuli at the inflammatory locus by functional hypertrophy and subsequent modification of the immediate environment is of
vital importance in the.functioning of macrophages at sites of tissue
injury and repair.

The increased pinocytic

activ~ty

and content of

hydrolytic enzymes of the activated macrophage suggest an increased
synthetic activity requiring an abundant and continuous supply of
metabolic energy.

Therefore, investigations into the pathways of

energy supply and production would add further insight into the
energetics of activation and maturation of the inflammatory macrophage.
B.

Macrophage Metabolism
1.

Mononuclear phagocyte vs. polymorphonuclear leukocyte

The biochemical characterization of leukocyte function has
yielded valuable information concerning the metabolic consequences
underlying many macrophage and PMNL functions in host defense physiology.

However, a direct comparison of leukocyte metabolism is com-

plicated by the fact that several morphologically different types of
white blood ce+ls exist and are distinctive in their complement of
enzymes and other features of their metabolism.

Furthermore, a homo-

geneous white cell population may display significant alterations in
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its metabolic patterns depending upon the functional state of the cell
(e.g. resting vs. phagocytizing, stage of differentiation, etc.) or
whether the cells were derived from the normal or diseased state.
Therefore such factors must be considered in attempting to critically
review or evaluate leukocyte metabolism.
Until recently, the biochemical properties of the PMNL have
received almost exclusive attention in evaluating leukocyte metabolism
due to the relative ease of obtaining a homogeneous population from the
peripheral blood or inflammatory exudate.
kocyte metabolism have consequently been

The general aspects of leuthoroughl~

reviewed (15, 67,

124). Since the role of the PMNL in host defense reactions is inti-

mately related to its ability to engulf and destroy a wide variety of
microorganisms, the metabolic events accompanying phagocytosis by
leukocytes have received considerable attention and have been extensively revie~ed (66, 67).

In contrast, the biochemical literature per-

taining to macrophage metabolism is relatively sparse when compared
to the PMNL.

This is due in part to the smaller yields of a homo-

geneous population of macrophages from blood, tissue, or exudate preparations.

Recently, however, relatively pure suspension of macro-

phages have been obtained from lung, peripheral blood, and peritoneal
cavity (7, 85 ) resulting in more extensive investigations into the
functional biochemistry of the macrophage (4, 68).
2.

Macrophage carbohydrate metabolism and energy supply

The relative contribution of either glycolysis or oxidative
I

respiration as the principal energy source is significantly different
among the various macrophage populations examined.

The primary energy
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source for the blood monocyte and peritoneal macrophage is glycolysis;
the alveolar macrophage however appears to be more dependent on oxidative mechanisms (7, 85).

Harris and Barclay (55 ) observed that

most of the glucose utilized by peritoneal macrophages was converted
to lactate, even in the presence of adequate oxygen, and that under anaerobic conditions glycolysis supplied cellular energy reQuirements.
Thus, they concluded that peritoneal macrophages are facultative
anaerobes which utilize glycolysis as their principal energy pathway.
Recently, West et al.

(135) confirmed the high glucose utilization

(31-37Junoles/hr/108 cells) displayed by peritoneal'macrophages and
also demonstrated a high aerobic lactate production.

In addition, a

comparison of the rates of glucose utilization by PMN leukocytes, lymphocytes and macrophages indicated that the macrophage is the most active
of the three cell types studied.
Glucose oxidation via the hexose monophosphate shunt is present
in the non-particulate fraction of PMN leukocytes and macrophages.

The

alveolar macrophage of the guinea pig is far more active in converting
glucose-l-14c and glucose-6-14c to 14co 2 than the peritoneal macrophage

(85).

The ratio of 14co2 production from glucose-l-14c to that from

glucose-6-14c is about 6:1 for the resting alveolar macrophage and 20:1
for the peritoneal macrophage.

The oxidation of glucose-6-14c to 14co 2

is extremely low in rat exudate PMNL ( 99 ), demonstrating a glucose-l14co2/glucose-6-14co2 ratio of 92 in the resting state.

Rat PMNL are

also character1zed by a low rate of oxygen uptake, a high aerobic glycolytic rate, and an active direct oxidative pathway, thus the resting
metabolism of peritoneal PMNL appears to be similar to that of the
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peritoneal macrophage.
3.

Macrophage lipid metabolism

Studies in macrophage lipid metabolism have addressed themselves
to two important unsolved problems in macrophage physiology:

1) the

tremendous lipid turnover of the cell membrane subsequent to endocytosis and

2) the function of macrophages at the site of fatty plaque

formation and their role in the clearance of blood cholesterol.
Day (32) and his colleagues have investigated the uptake and
metabolism of 14c-labelled cholesterol either in aqueous solution or
as a, component of chylomicra

and determined that exogenous cholesterol

was incorporated by macrophages and rapidly hydrolyzed.

The in vitro

synthesis of cholesterol from 14c-acetate was demonstrated by peritoneal
macrophages (31), along with cholesterol esterifying activity (33).
The principal fatty acids synthesized by peritoneal macrophages from
14 c-acetate were palmitic, oleic and linoleic acids.
The uptake of 14c-labelled fatty acids has been investigated
in the alveolar macrophage.

14c-linoleic and 14c-palmitic acid were

readily taken up by the macrophage, esterified and incorporated into
the triglyceride and phospholipid pool (42).

Inhibitors of glycolysis

effectively eliminated esterification, whereas inhibition of oxidative
metabolism

was without effect.

Furthermore, triglyceride incorporation

was investigated by the use of labelled tripalmitate, free or chylomicrabound, and the cellular incorporation of labelled palmitate was examined following 60 minutes of incubation.

Approximately 60% of the

labelled palmitate was found in the triglyceride fraction, 35% in
phospholipids, and 5% as free fatty acids.
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A prominent feature in atherosclerotic plaque formation is the
presence of a large number of lipid-laden macrophages infiltrating the
vascular endothelium.

Duff et al. (36) concluded that these lipid-

laden macrophages, called foam cells, were derived from the blood
monocyte population and were incorporated into the vessel wall while
the endothelium grew over the macrophages.

Recently, Cookson (27) has

proposed a dual origin for foam cells in atherosclerosis.

One cell

type contained numerous cytoplasmic fibrils suggestive of a smooth
muscle cell origin.

The other cell type manifested itself as a mac-

rophage, exhibiting many cytoplasmic processes, inclusions, and positive acid phosphatase reactive granules.

Cholesterol and its esters

have been shown to be fibrogenic and produce large granuloma when injected into connective tissue (1).

These authors suggest that phos-

pholipid injection somehow stimulated macrophage metabolism of cholesterol and thereby removes the cholesterol before it can exert a
fibrogenic effect on the vascular wall.
Thus the macrophage's role in the metabolism of a variety of
lipids establishes an important trophic function by the RES and clearly
implicates the macrophage as an important site of metabolic fuel uptake and processing in health and disease states.
4.

Macrophage protein synthesis

The fact that macrophages are quite active in the synthesis and
subsequent release of active molecules necessary to host defense mechanisms suggests,an active protein forming machinery.

On morphological

evidence alone, macrophages and monocytes are quite active in protein synthesis as shown by the presence of

abundan~

endoplasmic reticulum and
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ribosomes.

Cohn et al. (21) have demonstrated in macrophages cultured

in vitro that, following a pulse of leucine- 3 H, a flow of newly formed

--

protein occurs from the site of protein synthesis in the endoplasmic
reticulum through the Golgi apparatus, and finally to the primary lysosome.

These authors concluded that the majority of the newly syn-

thesized prote.in accumulated in Golgi vesicles prior to their fusion
with endocytic vacuoles.
Interferon represents a heterogeneous class of antiviral proteins produced in many tissues in response to viral infection.

Several

investigators have now clearly established that macrophages can produce
and secrete large amounts of interferon.

Acton and Myrvik (2) demon-

strated that alveolar macrophages can produce interferon following the
in vitro inoculation of parainfluenza-3 virus.

Incubation of normal

alveolar macrophages with this substance before challenging the macrophages with pox virus protected the cells against destruction.

Perito-

neal macrophages are also capable of producing interferon which is detectable in the culture medium two hours following the exposure of macrophages to viral agents (116).
Stecher and Thorbecke (118) have studied t·he in vitro incorporation of 14c-labelled amino acids into serum proteins by macrophages.
By utilizing autoradiographic and immunoelectrophoretic techniques,
they found that peritoneal macrophages synthesize in vitro Blc globulin
(C'3) and transferrin far more actively than either thoracic duct
lymphocytes or,blood leukocytes.

Although the macrophage is important

for complement component synthesis and probably the major site of complement formation in lymphoid tissue, it must be realized that it is
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probably not the only cell capable of producing these proteins.

In all

likelihood the parenchymal cells of the liver are also capable of synthesizing serum complement proteins.
Blood monocytes and peritoneal macrophages do not normally synthesize DNA under culture conditions (126), although following stimulation by an adjuvant, macrophages are able to divide and incorporate
thymidine into DNA.
macrophages (17).

Active RNA synthesis has been demonstrated in
Utilizing 3H-uridine and radioautographic techniques,

macrophages incorporate uridine initially into the nucleus and nucleoli
followed by migration of the label into regions of the cytoplasm containing ribosomes.

5.

Phagocytosis associated metabolism in PMNL and macrophages

Phagocytosis is associated with profound alterations in the
metabolism of phagocytic cells.

The nature and magnitude of these

metabolic perturbations vary and are ultimately dependent upon a host
of factors including:

1) the cell type (PMNL vs. macrophage),

2) the

origin of the phagocytic cell (blood, lung, or peritoneal cavity),
3) the type of particle ingested (bacteria vs. synthetic), and

4) the

incubation conditions (serum concentration, gas phase, cell suspension
or monolayer, etc.).
a.

PMN Leukocytes

Until recently, the PMNL has been the phagocytic cell population
which has been most studied in an effort to understand the metabolic
events accompanying phagocytosis ( 6~.

For example, it has been demon-

strated that the uptake of particulate matter by the PMNL is accompanied
by a stimulation of oxygen consumption, as well as by increases in aerobic
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and anaerobic glycolysis, glycogenolysis, hexose monophosphate shunt
activity, lipid turnover, and formate oxidation (23, 63, 106, 107).
Glycolytic inhibitors (e.g. sodium fluoride and iodoacetate) have a
profound inhibitory effect on phagocytosis, whereas the respiratory inhibitors (e.g. sodium cyanide and antimycin A) have little effect.
~hagocytosis

is clear that

It

by PMNL is an active process requiring a

net expenditure of energy derived primarily from glycolysis.
The dramatic respiratory burst that is associated with phagocytosis has been linked functionally to a bactericidal mechanism in the
PMNL.

Klebanoff (70) has postulated an effective antimicrobial scheme

consisting of a halide, myeloperoxidase, and the production of hydrogen
peroxide.

The increment in oxygen uptake subsequent to phagocytosis ap-

pears to be largely insensitive to inhibitors of cytochrome-linked respiration and is accompanied by the direct oxidation of glucose via the
hexose monophosphate shunt.

Two oxidases have been demonstrated in the

PMNL capable of producing hydrogen peroxide (12, 145).

It ·has been sug-

gested that the activation of one of these two oxidases during phagocytosis accounts for the increased oxygen utilization and direct oxidation
of glucose-l-14c due to the generation of NADP either by indirect coupling
with an NADPH lactic dehydrogenase or by direct NADPH oxidation.
b.

Macrophages

The recent advent of improved techniques for separating mononuclear cells from the peritoneal cavity, lung, or peripheral blood has
elicited quantitative information concerning the metabolic events of
I

macrophages during phagocytosis.

Oren et al. (85) compared the meta-

bolic characterizations of peritoneal macrophages and PMNL along with
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alveolar macrophages harvested from the guinea pig.

Following the in-

gestion of starch particles, these authors observed that both respiration and glycolysis were stimulated in peritoneal macrophages as evidenced by a three-fold increase in oxygen uptake concomitant with a
ten-fold increase in the recovery of 14coz from glucose-6-14c.

Phago-

cytosis by peritoneal macrophages was not impaired by anaerobiosis, inhibitors of respiration (1o-3M cyanide) or by uncouplers of oxidative
phosphorylation (1o-4M 2,4-dinitrophenol).

However, the glycolytic in-

hibitors, sodium fluoride (1o-2M) and iodoacetate (1o-4M), exerted a
dramatic inhibitory effect on phagocytosis.

Thus it was concluded that

the peritoneal macrophage derived its energy needs for phagocytosis
from glycolysis.
The alveolar macrophage, with a resting respiratory rate three
times that of the peritoneal macrophage, demonstrated only a slight increase in oxygen uptake or 14coz production from either glucose-l-14c
or glucose-6-14c following phagocytosis.

Furthermore, phagocytosis by

alveolar macrophages was markedly depressed in the presence of inhibitors of both oxidative and glycolytic metabolism.
Cytochemical investigations involved with the metabolism of alveolar and peritoneal macrophages basically concur with the biochemical
evidence that alveolar macrophages require oxidative metabolism to meet
energy demands while peritoneal macrophages derive their energy needs
predominantly from glycolytic metabolism.

Portugalov et al. (92) demon-

strated that peritoneal macrophages displayed high activity of such
glycolytic enzymes as phosphorylase and lactic dehydrogenase, whereas
the alveolar macrophage demonstrated higher levels of tricarboxylic
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acid cycle enzymes than did the peritoneal macrophage. '
In contrast to the PMNL where phagocytosis was associated with
a three-fold increase in the ratio of l4co 2 from glucose-l-l4c to
glucose-6-l4c, Oren et al. (85) could not demonstrate any significant
increase in hexose monophosphate shunt activity in either the alveolar
or peritoneal macrophage subsequent to phagocytosis.

However, West

et al. (135 ) calculated hexose monophosphate shunt activity in guinea
pig peritoneal macrophages and were able to demonstrate a small but
significant increase during phagocytosis.
Recently Romeo et al. (101) have analyzed the link between the
stimulated respiration and HMP shunt activity in the macrophage.

Their

results show a stimulation of both processes within seconds after the
addition of bacteria.

Furthermore, NADPH oxidase activity has been

demonstrated in macrophage 20,000 x g subcellular fraction suggesting that the activation of this oxidase, producing hydrogen peroxide, may be the event linking the stimulation of macrophage respiration to that of HMP shunt activity, a mechanism similar to that found
in the PMNL.
Stimulation of macrophage metabolic pathways is not only dependent upon particle ingestion but also on the state of maturation of
the mononuclear cell population.

Nonstimulated macrophages washed from

unstimulatedmouseperitoneum displayed no respiratory burst during
phagocytosis (68). However,peritoneal macrophages harvested five days
following the intraperitoneal injection of caseinate, demonstrated the
typical respiratory response subsequent to the ingestion of particles.
The metabolic requirements for macrophage pinocytic activity
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have been investigated in the mouse peritoneal macrophage (16) and
are clearly distinctive from those required for phagocytosis.

Pino-

cytosis by the peritoneal macrophage was depressed by inhibitors of
respiration (1o-5M cyanide, 1o-7M antimycin A), by anaerobiosis, and
by inhibitors of oxidative phosphorylation (0.6 g/ml oligomycin,
10-6M 2,4-dinitrophenol).

Pinocytosis can also be arrested by inhi-

bitors of protein synthesis suggesting that the synthesis of new plasma
membrane is probably required for continuing membrane interiorization
processes.

6.

Glycogen metabolism in the PMNL

The preceding summary of selected aspects of the metabolism of
PMNL and macrophages have emphasized the major role performed by aerobic
and anaerobic glycolysis in meeting the energy demands of phagocytic
cells.

The high rate of glucose utilization in the macrophage and the

accelerated rates of glycolysis demonstrated by PMNL and macrophages
during the endocytic event necessitate

a ready supply of glucose in

order to maintain functional integrity.

Furthermore, at the inflam-

matory site, where low oxygen and substrate supply may prevail, it would
be advantageous if exudate cells were able to store glucose in a reserve
form to meet continual energy demands.

Glycogen is the principal macro-

molecular storage form of carbohydrate in animal cells and, in concert
with glycogen synthetic and degradative enzymes, functions as a dynamic
ready source of glucose.
Investigations approaching the study of glycogen metabolism and
#

its regulation in white blood cells have primarily focused attention on
the leukocyte phagocytic cell population.

Early studies using histological
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techniques demonstrated that most of the glycogen in circulating white
blood cells is found in neutrophils and platelets, while both lymphocytes
and monocytes contained relatively small amounts of stainable glycogen.
wachstein (130) demonstrated that eosinophils and basophils contained
glycogen but in much smaller amounts than in the neutrophil.

This his-

tochemical data in conjunction with the relative ease of procuring a
homogeneous population of blood leukocytes stimulated the appearance of
quantitative· estimates of leukocyte glycogen.
Wagner (131) estimated leukocyte glycogen, utilizing the micromethod of Pfluger (90), to be 4.2 micrograms per 106 granulocytic leukocytes and calculated that the glycogen content of leukocytes was in the
same order of magnitude as striated muscle (i.e. 0.5-1.0%).

Valentine

et al. (125) investigated the glycogen content of human leukocytes in
health and in various disease states by the anthrone technique (113).
The mean leukocyte glycogen per 1010 granulocytic leukocytes was 75.1 mg.
Leukocyte glycogen remained relatively unchanged during. fasting and the
postprandial rise in blood glucose.

Leukocytes obtained from chronic

myelocytic leukemic patients displayed a glycogen content approximately
one half that of normal subjects.

In contrast, leukocyte glycogen in

polycythemia vera was elevated to a mean value per 1010 leukocytes of
116.2 mg.
Recently, an elegant study on leukocyte glycogen turnover and
the macromolecular state of leukocyte glycogen was performed by Scott
et al. (112).' The glycogen content of human leukocytes averaged 7.36 +
2.05 mg glycogen per 109 neutrophils and, when placed in a glucose-free
medium, decreased 38% following a two hour incubation.

Leukocyte glycogen
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synthesis was investigated in vitro by determining the glucose level at
which intracellular glycogen was not consumed and the glucose level
which provided maximal glycogen resynthesis.

The glucose load which

gave no net change in leukocyte glycogen for 60 minutes of incubation
was found to average 17.6 mg %, while the maximal change in glycogen
content was obtained at a glucose load of 200 mg %.

After preincu-

bation of leukocytes in glucose-free medium, glycogen resynthesis with
glucose-l4c was estimated and revealed that nearly 90% of the intracellular radioactivity was found in the isolated glycogen fraction. An
electron micrograph study of leukocyte glycogen revealed a rather
uniform particle size of about 20-30

~

in diameter, unlike liver gly-

cogen particles which appear in a spectrum of sizes ranging from 40 to
200 II¥-t in diameter (ll2).
In view of the observations that leukocyte glycogen levels appeared to be markedly labile in various physiological and disease states,
several investigators have attempted to elucidate those factors controlling glycogenolysis and glycogenesis in the leukocyte.

Williams

and Field (137) measured leukocyte phosphorylase activity in normal
humans and in two patients with glycogen storage disease with low liver
phosphorylase activity.

The mean level of leukocyte phosphorylase was

29.6 micrograms of inorganic phosphorus

per 107 leukocytes in normal

patients and an abnormally low mean value of 6.3 micrograms of inorganic
phosphorus per 107 in those patients manifesting glycogen storage
disease.

The authors concluded that the determination of leukocyte

phosphorylase activity derived from a blood sample may assist in diagnosing certain glycogen storage diseases, ideally eliminating the need
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for a liver biopsy.

Glycogen phosphorylase was assayed in normal leu-

kocytes and those derived from patients with chronic granulocytic or
lymphocytic leukemia (144).

Their results indicated that normal leu-

kocyte phosphorylase existed predominantly in .the active form (i.e.
active in the absence of 5'-AMP) suggesting that this leukocyte enzyme
is closely rel·ated to liver phosphorylase.

Phosphorylase levels in

leukemic leukocytes did not differ significantly from the normals.
The properties of leukocyte glycogen phosphorylase were further
studied in rats with chloroma, a tumor composed entirely of immature
granulocytes (143).

Two forms of the enzyme were demonstrated to

exist, an active form exhibiting 65-80% of its activity in the absence of 5'-AMP and an inactive form that was not significantly active
even in the presence of the nucleotide.

The authors noticed striking

similarities in the properties of leukocyte glycogen phosphorylase when
compared to liver phosphorylase.
Sbarra and Karnovsky (106) observed that, when leukocytes are ingesting latex particles in a glucose-free medium, glycogen breakdown was
accelerated during the first fifteen minutes of incubation.

However,

these same authors found that in the presence of glucose no change in
glycogen content occurred during phagocytosis.

Recently, Stossel et al.

(120) incubated leukocytes with latex particles in the absence of glucose and demonstrated that during the first fifteen minutes the rate
of glycogenolysis was accelerated while glycogen phosphorylase or synthetase activity did not significantly differ from leukocytes incubated
without particles.

Epinephrine and glucagon, hormones which increase

phosphorylase activity in liver preparations, had no effect in leukocyte
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phosphorylase activity, although Williams and Field (13() did report
. that glucagon increased phosphorylase activity.
The biosynthesis of glycogen via glycogen synthetase or transferase has been demonstrated in human PMNL (103) and in lymphocytes (57).
In normal human PMNL,synthetase activity existed only in the glucose-6phosphate dependent D-form, whereas lymphocytes possessed the system
for interconversion between the D and I-form (i.e. independent of glucose-6-phosphate).

However, in leukocytes from diabetic patients, gly-

cogen synthetase was found in both the I and D-form (45) and the D to I
transformation was greatly increased by insulin treatment.

Leukocytes

from rat peritoneal exudates differed from human PMNL in that incubation
greatly stimulated the D to I transformation in both normal and diabetic
leukocytes (102). Recently Wang et al. (132) incubated human PMNL in a
glucose-free buffer for two hours and observed a large decrease in glycogen content and phosphorylase activity.

The subsequent addition of

a 2 mg/ml glucose load resulted in a three-fold increase in ·the I activity, thus demonstrating that a D to I interconversion system, similar
to those found in liver, muscle and rat PMNL preparations, is present in
normal human PMNL.

Insulin had no demonstrable effect on

either the D to I conversion of glycogen synthetase or on the glycogen
content of human PMNL.

1.

Glycogen metabolism in inflammatory cells

Information regarding the role of glycogen in inflammatory exudate cells is meager .and consists primarily of histological studies
demonstrating the presence of stainable glycogen deposits.

Page and

Good (87}, utilizing the skin window technique of Rebuck followed the
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progression of phagocytic cells infiltrating into the iQflammatory site
in neutropenic patients.

They observed a marked depletion of mononuclear

cells at the inflammatory site in the absence of circulating neutrophils
and concluded that viable leukocytes somehow contributed to the subsequent appearance of macrophages in the inflammatory response.

Wulff

(141), utilizing the periodic acid-Schiff (PAS) technique to stain for
glycogen~

investigated the glycogen content of leukocytes and macrophages

infiltrating into the inflammatory locus.

Initially, neutrophils at the

exudate site were observed to contain variable amounts of PAS positive
reaction product and as the inflammatory reaction proceeded, the neutrophils stained more intensely.

With the appearance of macrophages,

neutrophil cytoplasmic fragments containing PAS positive reaction product were eventually observed to be amassed in membraneous aggregations
aroundthe macrophage population.

Rebuck et al. (97) also demonstrated

a direct transfer of neutrophil cytoplasmic glycogen to monocytes during
the course of the inflammatory response in humans.

Furthermore, they

observed a failure to transfer glycogen to mononuclear cells in severely
acidotic patients and suggested that the absence of membraneous-glycogen
in the mononuclear cells accounted for the depressed phagocytic ability
in diab.etic phagocytes and offered a mechanism for the increased susceptibility of diabetics to infection.
Recently, Scott and Cooper ( 111) studied the leukocyte glycogen
responses in guinea pig inflammatory exudates and demonstrated a dramatic rise in exudate leukocyte glycogen content as compared to blood
leukocyte glycogen levels.

Glycogen synthetase activity was found to be

significantly elevated in inflammatory leukocytes when compared to

30
peripheral blood leukocytes whereas, no significant change in glycogen
phosphorylase activity was detected in blood or exudate leukocytes.
Fasting the animals for up to three days appeared· to have no effect on
the glycogen

a~cumulating

ability of inflammatory leukocytes.

Thus the

authors concluded that the dramatic rise in leukocyte glycogen levels
at the inflammatory site is a significant event in the course of the
inflammatory response and can be accounted for by the relative increase
in the D-form of glycogen synthetase activity in the exudate leukocyte.

c.

Statement of the problem

In contrast to the abundant data which exists relevant to glycogen metabolism and its regulatory mechanisms in blood and exudate
leukocytes, no quantitative information is available that has explored
the role of glycogen or its metabolism within the inflammatory macrophage nor the mechanisms by which macrophages acquire glycogen at the
inflammatory site.
The overall purpose of this study is to evaluate in vitro the
physiological responses of macrophages derived from the inflammatory
site to exogenous glycogen.

Studies were undertaken to demonstrate

the mechanisms by which inflammatory macrophages acquire a large intracellular glycogen level from the inflammatory environment.

Additional

studies were also performed to examine those mechanisms employed by
inflammatory macrophages to maintain and utilize this carbohydrate reserve for continual macrophage function.
Furthe~more,

in the present study in vitro methods were developed

and employed to demonstrate macrophage glycogen synthesis and degradation by determining the activity of glycogen phosphorylase and synthetase
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and also by identifying an O<.-glucosidase of probable lysosomal origin.
In view of the observation that macrophages perform trophic
functions by ingestion of particulate material and the subsequent release of digested material into the extracellular environment, studies
were employed to examine a new trophic function of glucose export
and the relevant contribution of extracellular glycogen ingestion to
this glucogenic mechanism.

CHAPTER III
EXPERIMENTAL METHODS
A.

Experimental Animals
Male rats of the Sprague Dawley strain weighing between 250

and 350 grams were obtained from the Holtzman Co., Madison, Wisconsin.
The rats were housed at a room temperature of 74-75°F and maintained
on Purina Laboratory Chow and tap water ad libitum.
B.

Preparation of Inflammatory Cell Populations
1.

Exudate production

Inflammatory peritoneal exudates containing either PMNL or macrophages were induced by a modification of the procedure described by
Reed and Tepperman (99).

Rats were anesthetized with ether and in-

jected intraperitoneally (16 ml/100 gm body wt) with a 1% solution of
sodium caseinate (Eastman Kodak Co., Rochester, N.Y.) in 0.02M phosphate-buffered saline (PBS) at pH 7.4.

Non-inflammatory mononuclear

cells were obtained by lavage of normal rat peritonelw without prior
stimulation with caseinate.

Peritoneal exudates containing PMNL were

collected three hours following the introduction of caseinate while
inflammatory macrophages were harvested 96 hours after the injection
of the irritant.
2.

Harvesting procedures

Followitig decapitation, 20 ml of cold PBS containing 20 units/ml
of heparinwere injected into the peritoneal cavity, mixed briefly, and
32
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the exudate contents withdrawn with a large syringe and needle and
delivered into 50 ml Nalgene centrifuge tubes at 40C.

Cells were

sedimented by centrifugation at 150-200 x g for 10 minutes at 40C
and erythrocytes were effectively removed from the resulting cell
pellets by a 10 second exposure to 5.0 ml of distilled water followed
immediately by the addition of 15.0 ml of 1.2% saline to adjust isotonicity.

Following recentrifugation at 200 x g for 10 minutes at

4oc, cells were resuspended in cold glucose-free Hanks solution (GFH),*
pH 7.4, and washed twice in GFH prior to resuspension to their final
volume.
3.

Cell counting, differential and protein determination

Duplicate cell counts were ·obtained from 0.1 ml sample of the
final cell suspension diluted into 10 ml of GFH by routine hemocytometry
and expressed as 106 cells per ml of cell suspension.

Cell differentials

of PMNL, macrophages and lymphocytes were performed from Wright-stained
smears.

Cell protein was determined from a 1:100 dilution 'of cell sus-

pension according to the method of Lowry et al. (78) utilizing the Oyama
and Eagle modification (86) with bovine albumin as a reference standard.
C.

Glycogen Determination in Inflammatory Leukocytes and Macrophages
1.

Chemical determination of glycogen

Glycogen was isolated from inflammatory macrophages and PMNL by
a modification of the procedure originally described by Good, Kramer,
and Somogyi (50).

Glycogen was extracted by adding 2.0 ml of 30% KOH to

cell pellets (~0-120 x 106 cells) in 12 ml glass centrifuge tubes and
*Glucose-free Hank's balanced salt solution (pH=7.4), concentrations in
grams/L: NaCL 8.0, KCl 0.40,-Naz HP04 0.09, KHZ P04 0.06, Mg S04 0.1,
CaClz 0.14, Mg CLz 0.1, NaHC03 0.35.
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heating in a boiling water bath for 15 minutes until the pellet dissolved.

Following hydrolysis, tubes were cooled to room temperature

and 2.0 ml of 95% ethanol (ETOH) was added, mixed, reheated to near
boil, and stored at 4°C overnight to precipitate glycogen.

Glycogen

was sedimented by centrifugation at 1000 x g for 10 minutes at 4°C and
the resulting supernatant discarded.

The glycogen pellet was washed

twice in 60% ETOH and the final pellet drained briefly to remove the
alcohol.

1.0 ml of distilled water and 1.0 ml of 2.0 N H2S04 were added

to the dried glycogen pellets and heated in
hours.

~

boiling water bath for 3

Following acid hydrolysis of the glycogen, the tubes were cooled

to room temperature and neutralized to pH 7.0 by titrating with 1.0 N
NaOH and the final volume brought to 5.0 ml with distilled water.

Dup-

licate 1.0 ml aliquots were added to 4.0 ml :of glucose oxidase reagent
(Worthington Biochemical Co., Freehold, N.J.) and color development
read after 60 minutes of incubation at 37°C using a Klett-Summerson
colorimeter with blue filter (400-450

~).

Results are

exp~essed

as

either fg of glycogen per mg of protein or /<g glycogen per 106 cells.
2.

Incorporation of 14c-U-glucose into macrophage glycogen

4.0 ml of 96 hour inflammatory macrophages (30 to 40 x 106/ml)
in GFH, pH 7.4, were incubated at either 370 or 4°C in 25 ml Erlenmeyer
flasks containing 14c-U-glucose at a final concentration of 10 mM.
14c-U-glucose (specific activity 285 mC/mmole) was diluted with nonradioactive glucose in GFH to a specific activity of either 0.1 or
1.0 ;tCi/10 mM glucose.

Following the incubation interval, the contents

of the flasks were transferred to 12 ml glass centrifuge tubes at 4°C
and the macrophages washed twice in cold GFH to remove any extracellular
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14c.:.glucose.

2.0 ml of 30% KOH was added to the final'macrophage pellet

and glycogen precipitated by the method of Good, Kramer, and Somogyi (50)
as described above.

Following two washings in 60% ETOH, the final gly-

cogen pellet was dissolved in 1.5 ml of. distilled water and duplicate
0.5 ml aliquots of the glycogen solution were added to 10 ml of PCS and
counted in the Isocap 300 (Searle Analytic Inc., Des Plaines, Illinois)
for 10 minutes.

Activity was expressed as the dpms incorporated into

macrophage glycogen per mg protein per incubation time.
3.

14c-glycogen isolation from rat liver

Rat liver 14c-glycogen was prepared by the.incorporation of 14cU-glucose into liver glycogen as described by Brown (11).

Male rats

weighing 300-350 gms were fasted overnight and anesthetized with sodium
pentobarbital (12 mg/300 gm).

2-deoxyglucose (40 mg/100 gm body weight)

was injected i.v. into the dorsal vein of the penis followed after 30
minutes with an intraperitoneal injection of D-glucose (150 mg/100 gm
body weight) containing 14c-U-glucose at a specific activit.y of 6.0 fCi/
mmole.

Following three hours of light anesthesia maintained by subcu-

taneous injection of pentobarbital, the rats were decapitated, the livers
quickly removed, weighed, cut into small pieces, and placed immediately
into 250 ml beakers containing hot 30/o KOH and heated to near boil with
stirring for 15 minutes.

After tissue digestion, beakers were cooled to

room temperature and 50 ml of 95% ETOH added, mixed and the contents
poured into centrifuge tubes and the glycogen allowed to precipitate
overnight at 4~C.

Glycogen pellets were centrifuged for 10 minutes at

200 x g and washed twice in three volumes of 60% ETOH.

The final gly-

cogen pellets were dissolved in distilled water and dialyzed (mol.
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weight cut off l2,QOO-l4,000) against water overnight at room temperature.

Following dialysis, glycogen was reprecipitated by adding l

volume of 95% ETOH, washed in 60% ETOH and dried in a vacuum desiccator.
The resulting glycogen was weighed and di.luted in GFH and activity expressed as cpm per mg of glycogen by adding 1.0 ml of a known concentration of l4c-glycogen in GFH to 10.0 ml of Phase Combination System (PCS)
Solubilizer and counted for 10 minutes in Isocap 300 Liquid Scintillation
System, using efficiency calculations based on quench correction factors
determined by the sample channels ratio method.
4.

Uptake of l4c-glycogen by inflammatory macrophages

4.0 ml of inflammatory macrophages (30-40 x 106 cells/ml) in GFH,
pH 7.4, were incubated in 25 ml Erlenmeyer flasks containing 10 mg/ml
of l4c-glycogen, specific activity (2-3 x 103 cpm/mg glycogen), at either
37oc or 4°C with shaking (60/min).

Following the incubation period,

contents of the flasks were transferred to 12 ml glass centrifuge tubes
at 4°C and the flasks rinsed with cold GFH.

Cells were washed twice in

cold GFH to remove extracellular l4c-glycogen and 2. 0 ml of 30% KOH was
added to the cell pellets and macrophage glycogen isolated by the method
of Good, Kramer, and Somogyi (50) as described above.

The final glyco-

gen pellet was dissolved in 1.5 ml of distilled water and duplicate 0.5
ml aliquots were added to 10 ml of PCS and counted in the Isocap 300 for
10 minutes.

Activity is expressed as the~g of l4c-glycogen incorporated

into macrophage glycogen per mg protein.
D.

Glycogen Regulatory Enzyme Determinations in Inflammatory Macrophage
l.

Macrophage phosphorylase activity

Macrophage phosphorylase activity was determined in the direction
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of polysaccharide synthesis by measuring the rate of liberation of inorganic phosphorus from glucose-1-phosphate in the presence of glycogen
by a modification of the method of Sutherland (121).

3.0 ml of 96 hour

inflammatory macrophages (20-40 x 106 cells/ml) in GFH, pH 7.4, were
incubated in 25 ml Erlenmeyer flasks containing 1.0 ml of additions at
37oc in a Dubnoff metabolic shaking bath (60/min) with air as the gas
phase.

Incubations were terminated by the rapid transfer of the flask

contents into 12 ml glass centrifuge tubes at 4°C, the flasks rinsed
with cold GFH, and the cell suspensions centrifuged at 200 x g for 10
minutes at 4°C.

Following centrifugation, the

su~ernatant

was discarded

and the macrophage pellets were resuspended in 2.0 ml of 0.1 M NaF at
4oc.

Macrophages were effectively disrupted by a 2 minute sonication

at 4oc using a Biosonik IV Sonifer (Brownwill Scientific Inc., Rochester,
N.Y.) with microprobe and centrifuged for 10 minutes at 3000 x g to remove cellular debris.

0.4 ml of the resulting sonicate supernatant was

added to duplicate 12 ml glass centrifuge tubes at 4°C cont·aining 1. 0 ml
of 0.05 M glucose-1-phosphate (pH 6.1) containing 5.7 mg/ml of glycogen
and 0.05 M NaF and either 0.1 ml of 0.02 M adenosine-5 -phosphate or
0.1 ml of distilled water.
included in each experiment.

Reagent blank tubes without sonicate were
Reaction mixtures were incubated for 15

minutes at 37°C and terminated by the addition of 2.0 ml of cold 5% TCA
and centrifuged for 10 minutes at 500 x g at 4°C.

Following centrifu-

gation, duplicate 0.2 ml aliquots of deproteinized supernatants were
added to cuvettes containing 0.8 ml of distilled H20 and inorganic phosphorus was determined by the method of Fiske and Subbarow (47).

3.0 ml

of molybdic acid reagent were added to each cuvette and, at 10 second
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intervals, 1.0 ml of elon reagent was added to each tube and incubated
for 15 minutes at 37°C.

Color development was read immediately in a

Klett-Summerson colorimeter using a red filter.

Results are expressed

as micrograms of inorganic phosphorus liberated per mg protein per 15
minutes of incubation.
2.

Macrophage

Macrophage

~glucosidase

~-glucosidase

activity

activity was measured by the formation

of glucose from maltose, isomaltose, and glycogen as described by Hers
(58).

A 96 hour inflammatory macrophage cell suspension (1-10 x 106

cells/ml) in saline was sonicated for 2 minutes at 4°C.

0.5 ml dupli-

cate aliquots of macrophage sonicate were added to 12 ml glass centrifUge tubes containing either (1) 0.5 ml of 8 mg/ml of glycogen in 0.1 M
acetate buffer, pH 4.0; (2) 4 mg/ml of maltose in 0.1 M acetate buffer,
pH 4.0; or (3) 4 mg/ml of isomaltose in 0.1 M acetate buffer, pH 4.0 and
incubated for 60 minutes at either 40 or 37oc.

Protein was determined

in the macrophage sonicate according to the method of Lowry. (78).

A

substrate blank containing 0.5 ml of substrate in 0.1 M buffer and 0.5
ml of saline was incubated with each experimental run.

4 mg/ml of mal-

tose substrate was also prepared in 0.1 M sodium cacodylate-HCl, pH 6.0;
0.1 M imidazole-HCL, pH 7.0-8.0; and 0.1 M glycine

-NaOH, pH 9.0 to

obtain a pH profile of macrophagec{-1,4 glucosidase activity.

Following

incubation, samples were deproteinized with 1 ml of 1.8% BaOH and 1 ml
of 2% ZnS04 and centrifuged for 10 minutes at 200 x g.

Duplicate 1.0 ml

aliquots of deproteinized supernatant were added to Hycell cuvette tubes
and glucose concentration determined by the glucose oxidase method with
the glucose oxidase reagent dissolved in .025 M tris-HCl buffer to
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inhibit the maltase present in corrnnercial preparations of glucose oxidase (28).

The ofglucosidase activity was measured by the difference

between the amounts of glucose present in samples incubated at 40 or
37oc and expressed as

~

glucose per mg of protein per 60 minutes of

incubation.
3.

Macrophage glycogen synthetase activity

Uridine diphosphate glucose: o(-1,4-glucana<-4-glucosyl transferase (E.C. 2.4.1.11), the enzyme responsible for the elongation of
the outer chains of glycogen, was determined by measuring the amount of
14c-glucose activity incorporated into macrophage glycogen from UDP-u-14c
glucose according to a modification of the method described by Gold and
Segal (48).

1.0 to 2.0 ml of packed 96 hour inflammatory macrophages

were sonicated in two volumes of 0.1 M glycylglycine buffer (pH 7.4) at
40C for 2 minutes and the sonicate centrifuged for 10 minutes at 3000 x g
at 4oc.

The assay mixture contained

~mol

of UDP-glucose,

O.~i

of UDP-

glucose -u-14c,26~ol of glycylglycine, pH 7.4, and 20 mg.of glycogen
in a total volume of 3.8 ml.

When the glucose-6-phosphate dependent or

D form of the enzyme was as,sayed, 0. 01 M glucose-6-phosphate was also
present.

The reaction was initiated by adding 0.2 ml of macrophage 3000

x g sonicate supernatant to the assay mixture in 25 ml Erlenmeyer flasks
and incubated at 37oc for 10 minutes with shaking (60/min).

The reaction

was stopped by the addition of 6.0 ml of hot 30% KOH to each flask and
the contents of the flasks transferred to 40 ml centrifuge tubes and
heated for 15 minutes in a boiling water bath.

Following heating, 0.5 ml

of saturated NaS04 was added to each centrifuge tube and glycogen precipitated with 14.0 ml of 95% ETOH.

The mixture was again heated to boil,
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cooled for 30 minutes at 4°C and centrifuged for 10 minutes at 200 x g.
The glycogen-Na2S04 pellets were dissolved in 5.0 ml of distilled water
and reprecipitated by adding 6.0 ml of 95% ETOH.
cooled and centrifuged as above.

The tubes were heated,

The glycogen pellet was dissolved in

distilled water to a final volume of 3.0 ml and duplicate 1.0 ml samples of the glycogen solutions were added to 10-15 ml of Phase Combining
System (PCS) Solubilizer, (Amersham/Searle Corp., Arlington Heights,
Illinois,) and counted in the Isocap 300 for 10 minutes.

Background

incorporation was determined in samples to which the enzyme was added
after the addition of KOH to the flask.

Enzyme activities are ex-

pressed as nanomoles of glucose transferred from 14c-uridine diphosphate
glucose (UDPG) to glycogen per 10 minutes per mg of protein.
4.

Macrophage glucose-6-phosphatase activity

Macrophage glucose-6-phosphatase activity was measured by the
liberation of inorganic phosphorus from glucose-6-phosphate as described
by DeDuve (34).

Inflammatory macrophages (40-50 x 106 ml) -.vere sus-

pended in 0.25 M sucrose and sonicated for 2 minutes at 40C using a
Biosonik IV (Brownwill Scientific Inc., Rochester, N.Y.) with microprobe.

Protein was determined in the macrophage sonicate according to

the method of Lowry (78).

Duplicate 0.5 ml aliquots of macrophage soni-

cate were added to 12 ml centrifuge tubes containing 0.5 ml of .04 M
glucose-6-phosphate, .001 M EDTA, and .007 M histidine monohydrate, pH
6.5, and incubated for 10 minutes at 37oc.

Enzyme blanks were determined

in tubes to which the macrophage sonicate was added after the addition
of 10% TCA and incubated for 10 minutes at 37°C.

Reagent blanks were

prepared by incubating 0.5 ml of the glucose-6-phosphate substrate with
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0.5 ml of 0.25 M sucrose.

Following incubation, 5.0 ml of 10% TCA were

added to assay and reagent blank tubes and all samples were centrifuged
for 15 minutes at 200 x g at 4°C.

1.0 ml of deproteinized supernatant

was added to cuvettes and inorganic

p~osphorus

method .of Fiske and Subbarow (47).

Activity was expressed as mg phos-

was determined by the

phorus liberated per 10 minutes per mg protein.
E.

Glucogenesis in Inflammatory Macrophages and Polymorphonuclear Leukocytes
Two ml of cells (20-50

x

106/ml) or derived sonicate were sus-

pended in GFH and added to 25 ml Erlenmeyer

flask~

at 4oc.

One ml of

additions was added and all incubations were conducted at 37°C with
air as the gas phase and the flasks were shaken at 60/minute in a
Dubnoff metabolic shaking bath.

Incubations were terminated by rapidly

freezing all samples along with appropriate blanks at -2ooc.

After

thawing, samples were deproteinized with 1 ml of 1.8% BaOH and 1 ml
of 2.0% ZnS04 and the glucostat method (Worthington Biochemical Co.,
Freehold, N.J.) was used to determine glucose concentrations from deproteinized supernatants.

Glucose concentrations are expressed

as~

glucose per mg of protein per hour of incubation.
F.

Statistics and Data Analysis
Throughout the entire study, all results are expressed as the

mean + the standard error of the mean with the number of independent
in vitro observations described as "n".

Non-paired analysis were em-

ployed, placing the confidence limit at 95% for all experiments.
I

CAAP~RIV

RESULTS
A.

Factors Regulating the Glycogen Content of Inflammatory Macrophages
1.

Inflammatory cellular yields from the rat peritoneal cavity

Lavage of normal, unstimulated rat peritoneal cavities yielded
an average 18-20 x 106 mononuclear cells per rat with small macrophages
and lymphocytes constituting 90% of the cell population recovered.
Caseinate induction resulted in consistently high'yields of inflammatory
exudate cells from the rat peritoneum; from the 3 hour exudate, 6-7 x
107 cells were collected from each rat with greater than 90% of the
cell population examined being PMNL.

The 96 hour inflammatory exudate

produced 2-3 x 108 cells per rat with inflammatory macrophages accounting
for 85-90% of the cell population; PMNL and lymphocytes comprised the
remainder of the exudative population.

Approximately 90% of the 96 hour

inflammatory cell population was observed to adhere to a glass surface
when incubated for 60 minutes in Leighton tubes; furthermore, the cells
avidly phagocytized latex beads,

o.~

in diameter, and carbon particles

as determined by light microscopy.
2.

Glycogen content of inflammatory PMNL and macrophages

The glycogen contents of caseinate-induced inflammatory PMNL and
macrophages harvested from the rat peritoneum are presented in Table 1.
The 96 hour

in~lammatory

macrophage was observed to contain a large in-

tracellular glycogen reserve.

When the glycogen level of inflammatory
42

TABLE 1
GLYCOGEN CONTENT AND DEPLETION IN INFLAMMATORY PMNL AND MACROPHAGES a.)

Cell Type

Number of
Incubation
Samples

Glycogen Content
JAg glycogen/106 cells

%of

control

Inflammatory
PMNL
Control .. 60 min at 4°C

4

9-55.:!:. 0.44

100

60 min in GFH at 37°C

4

5.53.:!:. 0.36

58

Inflammatory
Macrophages

a.)

Control - 60 min at 4oc

7

60 min in GFH at 37°C

6

11.79 .:!:.

l. 59

100

5.78.:!:. 0.58

49

4.0 ml (20-40 x 106/ml) of inflammatory macrophages were incubated in GFH for 60 minutes
at either 4° or 37°C. Glycogen content is expressed asfog glycogen per 106 cells.

+:-
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macrophages was compared with the 3 hour exudate PMNL,'.there was no significant difference in the glycogen levels of these two inflammatory
cell populations.

Furthermore, when either inflammatory PMNL or macro-

phages were incubated in glucose-free,Hanks (GFH) media for 60 minutes,
both cell populations exhibited a labile intracellular glycogen pool
as demonstrated by an approximately 50% reduction in either inflammatory
cell's carbohydrate reserve.
Figure 1 depicts the effect of incubation in GFH on the glycogen
content in inflammatory macrophages.

Increasing the length of incuba-

tion in a glucose-free media to 120 minutes did not further reduce the
glycogen levels in inflammatory macrophages.

This inability to further

deplete the intracellular glycogen store suggests that only a certain
fraction of macrophage glycogen is available for rapid mobilization as
a fuel reserve.
3.

Effect of anaerobiosis and phagocytosis on glycogen
content in inflammatory macrophages

Since the peritoneal macrophage has been demonstrated to ultimately rely on glycolytic mechanisms to meet energy demands under
anaerobic conditions (85), it was of interest to determine whether in
vitro incubations of inflammatory macrophages in the presence of a nitrogen atmosphere would markedly affect macrophage glycogen stores
(Table 2).

During 60 minutes of incubation under anaerobic conditions

in a glucose-free media, inflammatory macrophages did not demonstrate
a further reduction in their glycogen content when compared to macrophages incubated similarly with air as the gas phase.
Furthermore, since leukocyte glycogen breakdown has been shown

FIGURE 1
EFFECT OF IN VITRO INCUBATION IN GFH
ON MACROPHAGE GLYCOGEN CONTENT
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4.0 ml of macrophages (20-40 x 106/ml) were incubated at 37°C
in GFH shaking (60/min) for the various incubation intervals. Glycogen
content is compared with control value at 4° and expressed as per cent
of control. Each point represents the mean + standard error of at least
four experiments.

TABLE 2
EFFECT OF ANAEROBIOSIS AND PHAGOCYTOSIS ON THE GLYCOGEN CONTENT
IN INFLAMMATORY MACROPHAGES

In~ubation a.

)

Conditions

Number of
Incubation
Samples

Glycogen Content
~g glycogen/mg Protein

A.

Control - 60 min at 4°C

8

B.

60 min in GFH

8

58.5 .:!:..

c.

60 min + N2 Atmosphere

4

56.0 .:!:.. 11.8

D.

60 min+ Latex Particles b.)

4

40.0 +

110.3.:!:.. 12.8
6.12

3. 40 c.)

a.)

4.0 ml of inflammatory macrophages (20-40 x 106 cells/ml) were incubated at 37°C with
shaking (60/min) for 60 min. Glycogen content is expressed as ~g glycogen/mg protein.

b.)

Latex particles (0.8~dia) were added at a particle to cell ratio of 50:1 in a total
volume of 0.1 ml in GFH.

c. )

p {. 05 as compared to group B

+:""

0\
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to be accelerated during phagocytosis in the absence of\adequate glucose
in the media (23, 107), experiments were undertaken to determine if
macrophage glycogen provided additional fuel molecules during the course
of the phagocytic event.

When inflammatory macrophages were incubated

in the presence of latex particles (0.8~ in dia) in a glucose-free media,
the glycogen content of phagocytizing macrophages was significantly diminished when compared to non-phagocytizing macrophages (Table 2).

4.

Effect of glucose and exogenous glycogen on inflammatory
macrophage glycogen content

The maintenance of intracellular macrophage glycogen content by
the addition of either glucose or exogenous glycogen is presented in
Table 3.

Inflammatory macrophages were incubated in the presence of

lOmM glucose or 10 mg/ml of glycogen (Rabbit Liver Glycogen, Type III,
Sigma Co., St. Louis, Mo.) for 60 minutes and macrophage glycogen content determined.

The presence of lOmM glucose in the incubation media

adequately maintained macrophage glycogen content during the 60 minute
incubation interval.

Moreover, the addition of 10 mg/ml of exogenous

glycogen to the glucose-free medium also enabled macrophages to maintain
their intracellular glycogen pool.

In the presence of exogenous gly-

cogen, the glycogen content of inflammatory macrophages following 60
minutes of incubation did not differ significantly from those samples
incubated in the presence of a high glucose load.

In addition, incuba-

tion of exogenous glycogen with inflammatory macrophages in an anaerobic
atmosphere did not significantly diminish the

macrophage~'s

ability to

maintain glycogen levels when compared to samples incubated under air
atmosphere.

'

t

L

TABLE 3
EFFECT OF GLUCOSE AND EXOGENOUS GLYCOGEN ON INFLAMMATORY MACROPHAGE GLYCOGEN CONTENT

Incubation a· )
Candi tions

Number of
Incubation
Samples

Glycogen Content
jA.g Gl;ycogen/mg Protein

110.3 ~ 12.8 c.)

%of

Control

A.

Control - 60 min at 4oc

8

B.

60 min in GFH

8

58.5 ~

6.12

53

c.

60 min
+ lOmM Glucose

6

95.8 ~

4.20

87

6

85.4 ~ 9.08

75

3

76.6 +

70

D.

60 min
+ lOmg/ml Glycogen b.)

E.

100

60 min
+ lOmg/ml Glycogen
+ N2 Atmosphere

3.65

a.)

4.0 ml of macrophages (20-40 x 106/ml) were incubated·for 60 min at 37°C with shaking (60/min)

b.)

Rabbit liver glycogen (Sigma Co., St. Louis, Mo.) was dissolved in GFH to a final incubation
concentration of 10 mg/ml.
P values in determining significant differences between groups
gp A vs B
p <.01
gp A vs C,D
not significantly different
gp B vs E
P<·os

c.)

+:OJ
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5~

Effect of glucose or glycogen on the glycogen content
in glucose-depleted inflammatory macrophages

One approach to determine by what mechanism exogenous glycogen
is able to maintain macrophage glycogen content is shown in figure 2.
Incorporation of exogenous glycogen into the inflammatory macrophage
glycogen pool could occur by two possible mechanisms, i.e., phagocytosis of macromolecular glycogen particles or by the extracellular
hYdrolysis of glycogen to glucose with the subsequent transport of
glucose into the macrophage directed toward glycogen resynthesis.
Since an adequate glucose supply to maintain glycolytic mechanisms is
one necessary requirement for particle ingestion by phagocytic cells
(23), incubation of inflammatory macrophages in a glucose deficient environment would therefore suppress phagocytosis of glycogen particles.
Macrophage glycogen resynthesis from glucose can be adequately stimulated by preincubating macrophage cell suspensions for two hours in a
glucose-free medium.

The addition of lOmM glucose to glycogen-depleted

inflammatory macrophages initiated a dramatic increase in glycogen resynthesis by inflammatory macrophages, reaching control levels by 60
minutes of incubation.

In contrast, the addition of 10 mg/ml of gly-

cogen to macrophages with a low energy reserve in a glucose-free medium
did not result in any significant changes in macrophage intracellular
glycogen content.
6.

Incorporation of l4c-U-glucose into inflammatory
macrophage glycogen

14c-u-g{ucose was utilized to compare the rates of glycogen
synthesis in glycogen-laden inflammatory macrophages and glycogen
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FIGURE 2
EFFECT OF GLUCOSE (lOmM) OR GLYCOGEN (lOmg/ml) ON GLYCOGEN
CONTENT IN GLYCOGEN-DEPLETED MACROPHAGES
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4.0 ml of macrophages (20-40 x 10 6 /ml) were preincubated for
2 hours at 37°C with shaking (60/min) in GFH. lOmM glucose or 10 mg/ml
of glycogen were then added and glycogen content determined at 30 minute
intervals. Ea~h point represents the mean+ standard error of at least
three experiments.
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resynthesis in macrophage depleted of their glycogen pools (Figure 3).
Inflammatory macrophage cell suspension were preincubated in a glucosefree media at either 4° or 37°C.

Following the preincubation period,

lOmM glucose containing 0.1~ of 14c-U-glucose was added to each flask
and, following various incubation intervals, macrophage glycogen was
isolated and r·adioactivity counted from aliquots of dissolved glycogen.
Glycogen-laden inflammatory macrophages incorporated 14c-U-glucose into
intracellular glycogen at a rate of 27.2 + 3.8 x 103 dpm of 14c-glucose
per 30 minutes per gram of cell protein.

Glycogen resynthesis in gly-

cogen-depleted.macrophages was determined to be 71.5 + 4.4 x 103 dpm of
14c-U-glucose incorporated into macrophage glycogen per 30 minutes per
gram of cell protein.

The rate of 14c-glucose incorporation into macro-

phage glycogen was directly related to the length of incubation in both
macrophage populations (Figure 3).

Thus glycogen depleted macrophages

demonstrated an accelerated rate of glycogen resynthesis and suggests
a probable inverse relationship between macrophage glycogen concentration
and the percent of glycogen synthetase in the active form as has been
observed in such tissues as skeletal muscle (29), cardiac muscle, (62)
and liver (35).
7.

The influence of a pinocytic activator and insulin in
stimulating 14c-U-glucose incorporation into macrophage
glycogen

Pinocytosis affords the macrophage another mechanism of transporting extracellular solutes by membrane vesicle formation and in-

,

vagination into the macrophage interior.

Numerous factors stimulate

macrophage pinocytosis including anionic proteins, serum factors, ATP,
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FIGURE 3
INCORPORATION OF 14 c-U-GLUCOSE INTO INFLAMMATORY MACROPHAGE GLYCOGEN
EFFECT OF GLYCOGEN DEPLETION ON 14c-GLUCOSE INCORPORATION
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4.0 ml of macrophages (30-40 X 106/ml) were incubated in the
presence of lOmM glucose containing O.l~Ci of 14c-U-glucose per flask
and glycogen isolated from cell pellet.
Glycogen depleted macrophages were preincubated for 120 minutes
at 37°C in GFH prior to the introduction of 14C-glucose.
Radioactivity was counted from duplicate 0.5 ml samples of
isolated glycogen dissolved in 1.5 ml of distilled H20.
Each point represents the mean + standard error of at least
four experiments.
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and mucopolysaccharides (24).

Since albumin is one such activator of

macrophage pinocytic activity, experiments were undertaken to determine
whether activation of pinocytosis increased the incorporation of extracellular 14c-U-glucose into macrophage glycogen (Table 4).

Inflammatory

roacrophages incubated in the presence of 1% albumin doubled their incorporation of 14~-U-glucose into macrophage glycogen as compared to cells
incubated in a glucose-free media alone.
Insulin has been shown to be without effect in PMN leukocytes incubated in vitro in either augmenting glycogen synthetase activity or
increasing leukocyte glycogen levels (44).
cubated in the presence of insulin

Inflammatory macrophages in-

(200~U/ml)

did not demonstrate any

increased incorporation of 14c-U-glucose into macrophage glycogen.

How-

ever, the addition of insulin to the incubation media containing 1% albumin significantly decreased 14c-U-glucose incorporation into macrophage glycogen when compared to macrophages incubated in the presence
of 1% albumin alone (Table 4).
8.

14c-glycogen uptake by inflammatory macrophages

In view of the apparent significance that exogenous glycogen
serves as a source of energy reserve to the inflammatory macrophage and
the lack of any quantitative information concerning the ingestion of
this important fuel macromolecule, preliminary experiments were undertaken to determine whether l4c-labelled glycogen could be ingested in
vitro by inflammatory macrophages.

Figure 4 presents a plot of the in

vitro uptake of 14c-labelled glycogen by inflammatory macrophages in a
,
glucose-free media. 14c-glycogen was prepared from rat liver as described in Methods and dissolved in GFH containing unlabelled glycogen
to a final incubation concentration of 10 mg/ml.

Using a medium glycogen

TABLE 4
INCORPORATION OF l4c-U-GLUCOSE INTO MACROPHAGE GLYCOGEN
EFFECT OF INSULIN AND ALBUMIN PINOCYTIC ACTIVATION
Addition to a.)
Ineubation
Medium
.

Number of
Incubation
Samples

dpm of 14 c-U-glucose b.)
incorporation into
glycogen/mg protein/60 min

lOmM lhc-U-Glucose

8

71.9 .:!:. 2.23

10w1 l4c-U-Glucose
+ 1% Albumin

12

146.9 .:!:. 3.42

lOmM l4c-U-Glucose
+ 1% Albumin
+ 200~U/ml Insulin

13

122.8 .:!:. 3.15

a.)

4.0 ml of macrophages (30-40 x 106 cells/ml) were incubated with 1.0 ml of additions at
37°C with shaking (60/min) for 60 minutes.

b.)

Radioactivity was counted from duplicate 0.5 ml samples of isolated macrophage glycogen
dissolved in 1.5 ml of distilled H o.
2

Vl
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FIGURE 4
14c-GLYCOGEN UPTAKE BY INFLAMMATORY MACROPHAGES
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4.0 ml of macrophages (30-40 x 106 cells/ml) were incubated at
37oc and 4°C with 0.5 ml of 14c-glycogen in a total volume of 5.0 ml.
Radioactivity was counted from duplicate 0.5 ml samples of
isolated macrophage glycogen dissolved in 1.5 ml of distilled H20.
0.5 ml of a 100 mg/ml glycogen in GFH contained 90 mg/ml of unlabeled glycogen + 10 mg/ml of 14c-glycogen. Specific activity of
final 14c-glycogen solution was approximately 1600 cpm/mg of glycogen.

concentration of 10 mg/ml containing 16 x 103 cpm/ml of, 14c-glycogen,
the amount of isotope incorporated into inflammatory macrophage glycogen
by 15 minutes of incubation corresponded to lOfg of glycogen per mg of
cell protein.

Samples containing 14c-glycogen were incubated at 4°C

with each experimental run and any activity in the isolated glycogen was
subtracted from those samples incubated at 37°C.

The incorporation of

14c-glycogen was linear over a 30 minute incubation period utilized in
these experiments.

Assuming no change in the total macrophage glycogen

level of llOpg of glycogen/mg protein over the 15 minute incubation
period, the incorporation of exogenous glycogen amounted to approximately
10% of the total macrophage intracellular pool.

9.

14c-glycogen uptake in glycogen-depleted inflammatory
macrophages

Since glycogen-depleted macrophages manifested a marked inability
to increase their glycogen content in the presence of exogenous glycogen
in a glucose-free media, it was of interest to compare the rate of incorporation of 14c-glycogen by glycogen-laden and glycogen-depleted inflammatory macrophages.

In Table 5 is presented the in vitro incorpora-

tion of l4c-labelled glycogen by glycogen laden macrophages and by macrophages depleted of their glycogen reserve by a 2 hour preincubation in
a glucose-free media.

Incorporation of l4c-glycogen by glycogen-depleted

macrophages w~s markedly depressed in the presence of 10 mg/ml of 14c_
labelled glycogen at either 15 or 30 minutes of incubation at 37°C.
When compared to inflammatory macrophages containing their full complement of glycogen reserve, the ingestion of exogenous glycogen was depressed nearly 50% in glycogen-depleted inflammatory macrophages,

TABLE 5
14C-GLYCOGEN UPTAKE BY INFLAMMATORY MACROPHAGES
EFFECT OF GLYCOGEN DEPLETION ON 14C-GLYCOGEN UPTAKE
Number of
Incubation
Samples

l4C-Glycogen Content c.)
14

Macrophage a.)
Population

Incubation
Interval

Glycogen-Laden

15 min

4

29.69 ~ 0.75

100

15 min

4

12.56 ~ 0.63

56

30 min

4

36.26 ~ 1.60

100

30 min

4

21.38 ~ 1.92

56

Gly~ogen-Depleted

Glycogen-Laden
Gl~ogen-Depleted

a.)

b.)

c.)

~g

-c Glyco~e~

mg Protein b.)

%of Control

4.0 ml of macrophages (30-40 x 106/ml) were incubated at 37°C with 0.5 ml of 10 mg/ml of
14C-glycogen in a total volume of 5.0 ml.
Radioactivity was counted from duplicate 0.5 ml samples of isolated macrophage
dissolved in 1.5 ml of distilled H20.
14c-glycogen specific activity was 2100 cpm/mg of glycogen.

glycogen
/

VT
~
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suggesting a reduced functional endocytic capacity in inflammatory macrophages whose carbohydrate reserve has been severely diminished.
B.

Enzymes Regulating Macrophage Glycogen Metabolism
l.

Macrophage phosphorylase activity
a.

Effect of glycogenolysis on macrophage total
phosphorylase activity

Table 6 demonstrates that the initial total phosphorylase activity, derived from whole sonicates of 96 hr inflammatory macrpphages,
was 37.9 ~ l.56~g inorganic phosphorus (Pi) liberated per 15 minutes
per mg of protein.

Total macrophage phosphorylase activity was de1

termined in the presence of 5 -AMP in the reaction mixture.

Since it

was of interest to determine the relative states of macrophage phosphorylase activation prior to and

during active glycogenolysis, ex-

periments were performed to determine if any change occurred in macrophage total phosphorylase activity during 60 minutes of active glycogenolysis in a glucose-free media.

In Table 6 it is observed that in-

flammatory macrophages incubated in GFH demonstrated no significant change in total phosphorylase during the 60 minutes of active
glycogenolysis.
b.

Effect of exogenous glycogen on macrophage total
phosphorylase activity
I

The activation of macrophage 5 -AMP dependent phosphorylase
activity by exogenous glycogen is presented in Table

7.

Inflammatory

macrophages were incubated in GFH for 15 minutes in the presence or
absence of 10 mg/ml of exogenous glycogen in the incubation media.
Following the 15 minute incubation interval, total phosphorylase

TABLE 6
EFFECT OF GLYCOGENOLYSIS ON MACROPHAGE TOTAL PHOSPHORYLASE ACTIVITY a.)

Incubation
Intervals

Number of
Incubation
Samples

Total Phosphorylase Activity b.)
4g P;/15 min/mg protein

Control

10

37.9~1.56

15 min

10

42.3 ~ 4.31

30 min

5

42.3 ~ 5.68

60 min

5

39.9 ~ 4.50

a.)

3.0 ml of macrophages were incubated at 37°C with shaking (60/min) in GFH

b.)

Total phosphorylase activity measured in the presence of 5'-AMP was determined on
whole sonicates in 0.1 M NaF.

VI
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TABLE 7
EFFECT OF EXOGENOUS GLYCOGEN ON TOTAL MACROPHAGE PHOSPHORYLASE ACTIVITY

Additions to a.)
Incubation Medium

Number of
Incubation
Samples

Total Phosphorylase Activity b.)
M,g Pi/15 min/mg protein

Control

10

37.9.:!:. 1.56

15 min in GFH

10

42.3.:!:. 4.31

8

48.4 + 3.37

15 min + 10 mg/ml
Glycogen

a.)

3.0 ml of macrophages (20-40 x 106 cells/ml) in GFH were incubated with 1.0 ml of
additions at 37°C with shaking 60/min.

b.)

Total phosphorylase activity was measured in the presence of 5/-AMP and determined
from whole sonicates in 0.1 M NaF.

0'\
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activity was immediately determined on macrophage

sonic~tes.

Inflam-

matory macrophages incubated in the presence of 10 mg/ml of glycogen
significantly increased phosphorylase activity by nearly 30%, whereas
macrophages incubated in the absence of glycogen did not demonstrate
/

any further activation of 5 -AMP dependent phosphorylase activity.
c.· The active form of macrophage phosphorylase
An active or a form of the phosphorylase enzyme, whose activity
/

is measured in the absence of 5 -AMP, has been demonstrated in such
tissues as skeletal muscle (26), liver (139) and leukocytes (143, 144).

,

Since the form independent of 5 -AMP has been shown to be the fraction
of phosphorylase activity responsible for initiating glycogenolysis,
studies were attempted to determine what fraction of macrophage phosphorylase activity is in the active form.

The active and total phos-

phorylase activities derived from 3000 x g sonicate supernatant is presented in Table 8.

Total macrophage phosphorylase activity measured in

the presence of 5,-AMP was 41.2 ~ 1.82 g Pi/15 min/mg protein.

Macro/

phage active phosphorylase activity measured in the absence of 5 -AMP
was 30.4 ~ 1.86~g Pi/15 min/mg protein.

Thus approximately 73% of mac-

rophage phosphorylase activity was in the active form.

The macrophage

phosphorylase activity ratio (active phosphorylase activity/total phosphorylase activity) of 0.73 was similar to the 0.75 activity ratio of
liver phosphorylase (139) and the 0.80 activity ratio of leukocyte
phosphorylase (143).
d.

Effect of Mg++_ATP on macrophage phosphorylase activity

The conversion of inactive to active phosphorylase has been shown
to occur in crude liver extracts (94) and, more recently, in leukocyte

TABLE 8
ACTIVE AND TOTAL PHOSPHORYLASE ACTIVITY IN INFLAMMATORY MACROPHAGES
Number of
Incubation
Samples

.

Macrophage Phosphorylase Activity a.)
pg Pi[l_5 min/Plg protein

Total Phosphorylase
Activity
(+ 0.02 M 5/-AMP)

9

41.2 + 1.82

(- 0.02 M 5/-AMP)

9

30.4 ~ 1.86 b.)

Per Cent Activity in the
Active Form

9

73.1

Phosphorylase a Activity

a.)

Macrophage phosphorylase activity was determined on 3000 x g sonicate supernatants
in 0.1 M NaF.

b.)

Significantly different from total phosphorylase activity (p<.OOl).

/
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homogenates (143) by a mechanism involving a specific p:rotein kinase
requiring Mg++ and ATP.

In order to determine whether macrophage phos-

was also capable of interconversion of the inactive to active

pho~ylase

form, macrophage 3000 x g sonicate supernatants were incubated with
o.lM Mg-ATP and the inactive and active phosphorylase activities determin~d

(Figure 5).

The preincubation of macrophage 3000 x g sonicate

in O.lM NaF for 30 minutes decreased the percent of macrophage phosphorylase in the active form from 73% to 55%.

Following this preincu-

bation interval, the introduction of O.lM Mg++_ATP to the samples resulted in a nearly complete conversion of phosphorylase activity to the
active form by 15 minutes (90% in the active form).

Total phosphorylase

activity measured in the presence of 5"-AMP did not significantly change
throughout the incubation interval.
2.

Macrophage glucosidase activity
a. o\-1,4 and ~-1,6 glucosidase activity in inflammatory
macrophage

Since acid ~1,4 glucosidase is

capable of hydrolyzing maltose,

linear oligosaccharides, and the outer branches of glycogen to glucose
and of catalysing the transglucosylation from maltose to glycogen in
liver, skeletal muscle (58) and in human leukocytes (136), i t was of
interest to determine whether this mechanism of glycogen hydrolysis was
present in inflammatory macrophages.
determinations

of~

Table 9 contains the results of

-glucosidase activities measured at pH 4.0 in whole

sonicates of 96.hour inflammatory macrophages.

Macrophages exhibited

a large ~-1,4-glucosidase activity of 201.1 ~ 1.07~g of glucose hydrolyzed per hour per mg of protein utilizing maltose as the enzyme
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FIGURE 5
EFFECT OF Mg-ATP ON
INFLAMMATORY MACROPHAGE PHOSPHORYLASE ACTIVITY
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a) Macrophage 3000 xg sonicate supernatants were preincubated
at 37°C in O.lM NaF for 30 minutes prior to the addition of O.lM Mg+2-ATP.
b) Per cent in active form was determined by the phosphorylase
activity ratio '(activity- AMP/activity+ AMP).
c) Mean+ standard error of four experiments.

TABLE 9
o<-GLUCOSIDASE ACTIVITY IN INFLAMMATORY MACROPHAGES a.)
o{-1,4-Glucosidase b.)
4 mg/ml Maltose
201

~

(6)

1.07

o<.-1, 6-Gl.ucosidase b ·)
8. mg/ml Glycogen
27.0

~

(6)

2.0

4 mg/ml Isomaltose
4.43 ~ 1.08

(6)

a.) o<-glucosidase was determined at pH 4.0 from macrophage whole sonicates
and samples incubated for 60 min at 4° and 37°C.
b.) o(-glucosidase activity is expressed as~ of glucose hydrolyzed per
hr per mg protein.

0\
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substrate and 27.0

~ 2.0~

of glucose hydrolyzed per hour per mg of pro-

tein using glycogen as substrate.

~-1,6-glucosidase

activity resulted

in a very low activity of 4.43 ~ l.08~g of glucose hydrolyzed per hour
per mg of protein when isomaltose, a dissacharide comprised entirely of
~-1,6

glucosidic

bonds was added as substrate for glucosidase activity.

b. · Effect of pH on inflammatory macrophage 0<.. -1,4glucosidase activity
Lejeune et al. (76) reported that liver 0(-glucosidase had its
maximum activity at pH 4.0 and was present in the lysosomal fraction of
rat-liver homogenates.

Figure 6 presents the results of incubating mac-

rophage sonicates with maltose substrate at pH values ranging from 3.0
to 9.0.

Macrophage ~-1,4 glucosidase activity manifested its greatest

activity at pH 4.0, suggesting that acid pH optimum of macrophage glucosidase activity favors a lysosomal environment.
3.

Macrophage glycogen synthetase activity
a.

I and D forms of macrophage glycogen synthetase

Table 10 presents the glycogen synthetase or transferase activity of inflammatory macrophage 3000 x g sonicate supernatants.
Macrophage glycogen synthetase was found to exist in two forms, a dependent or D form, requiring the presence of glucose-6-phosphate and an
independent or I form, manifesting activity in the absence of glucose6-phosphate.

Macrophage dependent or total glycogen synthetase ac-

tivity measured in the presence of lOmM glucose-6-phosphate was 14.3 +
2.2mrm of UDP glucose incorporated into macrophage glycogen per 10
minutes per mg of protein, while the independent or I for.m of macrophage
glycogen synthetase was 0.84~ of UDP glucose incorporated into glycogen

FIGURE 6
EFFECT OF pH ON MACROPHAGE ~-1,4 GLUCOSIDASE ACTIVITY
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a) 0.5 ml of macrophage sonicate was incubated with 4 mg/ml
of maltose in a total volume of 1.0 ml for 60 minutes at 4° and 37°C.
I

b) Mean+ standard error of nine experiments.

TABLE 10
INFLAMMATORY MACROPHAGE GLYCOGEN SYNTHETASE ACTIVITY a.)
Number of
Incubated
Samples

~

~oles

of UDP glucose
incorporated into glycogen/
10 min/mg protein

Total Synthetase Activity
+ lOmM Glucose-6-Phosphate

8

14.3 .:': 2.23

Independent Synthetase Activity
- lOmM Glucose-6-Phosphate

8

0.84 + 0.08

Per Cent Activity in the
Independent Form

8

a.)

5.9%

Glycogen synthetase activity was determined on macrophage 3000 x g sonicate
supernatants in O.lM glycylglycine buffer.

0\
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per 10 minutes per mg protein and represented approximately 6% of the
total activity.
b.

Effect of glycogen depletion on macrophage glycogen
synthetase activity

In view of the observation that preincubation of macrophages in
a glucose-free media accelerated the rate of l4c-glucose incorporation
into glycogen, it was of interest to investigate whether an increase in
the activity of glycogen synthetase was the underlying mechanism for the
acceleration of glycogen resynthesis in glycogen-depleted macrophages.
In Table 11 is shown the results of a comparison of macrophage glycogen
synthetase activity, both in the glucose-6-phosphate independent and
dependent forms, from glycogen-laden macrophages and macrophages depleted of their glycogen reserve by a 2 hour preincubation in a glucosefree media.

Subsequent to glycogen depletion macrophages exhibited a

dramatic 267% increase in the glucose-6-phosphate dependent form of the
enzyme to a value of 38.2

~ 2.~~

of UDP glucose incorporated into

glycogen per 10 minutes per mg of protein.

The glucose-6-phosphate in-

dependent form of glycogen synthetase was observed to increase over five
fold to a value of 4.69 ~ 0.7~\m of UDP glucose incorporated into glycogen per 10 minutes per mg of protein.

As a consequence of this dra-

matic rise in the independent form of macrophage glycogen synthetase in
glycogen depleted macrophages, glycogen synthetase activity in the independent form increased 83% as compared to glycogen laden macrophages.
4.

Macrophage glucose-6-phosphatase activity

Glucose-6-phosphatase catalyzes the hydrolysis of glucose-6phosphate to inorganic phosphate and glucose and its activity has been

:''II

TABLE 11
EFFECT OF GLYCOGEN DEPLETION ON MACROPHAGE GLYCOGEN SYNTHETASE ACTIVITY a.)

Incubation
Conditions
Glycogen-Laden
Glycogen-Depleted b · )

Glycogen-Laden
Glycogen-Depleted

Number of
Incubation
Samples

Glycogen
Synthetase
Activity

~ UDPG Glucose

Incorporatedinto glycogen/
10 min/mg protein

% of Control

8

D-form

14.3.:!:. 2.23

100

4

D-form

38.2 .:!:. 2.15

267

8

I-form c ·)

0.84 + 0.08

100

4

I-form

4.69.:!:. 0.73

558

a.)

Glycogen synthetase activity was determined on macrophage 3000 x g sonicate supernatant
in O.lM glycylglycine . .

b.)

Glycogen-depleted macrophages were preincubated for 2 hours at 37°C in GFH.

c.)

Percent activity in I-form in glycogen-laden macrophages = 5.9%.
Percent activity in I-form in glycogen-depleted macrophages = 10.9%.

~
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reported in liver, kidney and in small intestine (59). \Since glucose-6phosphatase represents the final key regulatory step in glycogen metabolism in terms of glucose output, it was of interest to determine
whether inflammatory macrophages could demonstrate hydrolytic activity
towards glucose-6-phosphate.

Table 12 presents the glucose-6-phosphatase

activity of inf-lammatory macrophage sonicates in 0.25M sucrose.

Macro-

phages displayed a significant glucose-6-phosphatase activity of 1.52 +
O.llmg Pi/mg protein/10 min, suggesting the enzymatic capability to
liberate free glucose from intracellular glycogenolytic mechanisms.
C.

Glucogenesis in Inflammatory Macrophages
Since the macrophage is known to perform trophic functions by

the ingestion of soluble macromolecules and the subsequent transport
of digested products back into the immediate extracellular environment,
it was of interest to determine whether the inflammatory macrophage
responded trophically to the uptake and intracellular digestion of exogenous glycogen by the production and subsequent transport of glucose,
i.e. glucogenesis, back into the extracellular milieu.
1.

Glucose production in normal and inflammatory exudate cell
populations

In Table 13, the glucogenic capability of unstimulated peritoneal mononuclear cells, inflammatory PMNL and inflammatory macrophages
is evaluated by measuring the glucose liberated by these cell populations into a glucose-free media.

In the absence of exogenous glycogen,

there was no significant amount of glucose liberated during a 3 hour
incubation period by the three peritoneal cell populations.

The ad-

dition of 50 mg of glycogen to the incubation flasks significantly

TABLE 12
GLUCOSE-6-PHOSPHATASE ACTIVITY IN INFLAMMATORY MACROPHAGES

Cell Population a.)
Inflammatory
Macrophage
Sonicate

Number of
Incubation
Samples

12

Glucose-6-Phosphatase b.)

Acti~ity

1.52 + 0.11

a.)

Inflammatory macrophages were sonicated in 0.25M sucrose at 4°C.
Duplicate samples were incubated at 4° or 37°C for 30 min.

b.)

Glucose-6-phosphatase activity is expressed as mg Pi/mg protein/10 min.

-.:]
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TABLE 13
GLUCOSE PRODUCTION IN NORMAL AND INFLAMMATORY EXUDATE CELL POPULATIONS a.)
Glucogenesis

-,HS of glucose/mg protein/hour

Additions to incubation media
Cell Population

No Additions

Unstimulated
Peritoneal Cells

0

Inflammatory
Leukocytes

0.63 .!.. 0.31 (3)

Inflammatory
Macrophages

0.23

a.)

Glycogen (10 mg/ml)
(3)b·)

~

0.13 (3)

Glycogen (10 mg/ml) +
NaF ( 3 mM)

2.26.!.. 0.78

( 4)

1.63 .!.. 0.98

(4)

1.42 .!.. 0.13

(3)

1.80 .!.. 1. 06

(4)

2.68 .!.. 0.35

( 4)

12.30 ~ 1.75c.)(5)

Two ml of cells (20-50 x 106/ml) were suspended in GFH in~ total incubation volume of
3 ml. Incubations were for 180 min. at 37°C. Glucose production is expressed as pg
of glucose per mg of protein per hour. All data represent the differences as compared
to control samples incubated at 4°C.

b.)

Number of experiments

c.)

Significantly different from the unstimulated and leukocyte populations (p~.OOl)

--::J
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augmented the glucogenic response of all three cell types examined.
While the addition of 3 mM NaF, a potent glycolytic inhibitor, to the
incubation media containing exogenous glycogen did not significantly
alter glucose liberation in either the unstimulated peritoneal mononuclear cells or in the inflammatory PMNL, glucose production by the
inflammatory macrophage was augmented from 2.68 ~ 0.35~ glucose per
mg protein per hour to 12.30 ~ 1.75~ glucose per mg protein per hour,

nearly a six fold increase in the macrophage glucogenic capacity.

In

contrast, macrophages did not manifest a glucogenic response to 3 mM NaF
when exogenous glycogen was deleted from the incubation media.

Further-

more, incubation of 50 mg of glycogen in GFH for 3 hours at 37°C did not
result in any measurable glucose liberation into the media.
Glucogenesis by inflammatory macrophages as related to length of
incubation is represented in Figure 7.

The rate of macrophage gluco-

genesis was directly related to the 3 hour incubation interval utilized
in these experiments.

Additional studies have also demonstrated that

the glucogenic rate was independent of exogenous glycogen concentration
above 8 mg/m1.

These results indicate not only that the rates of re-

actions involved in glycogenolysis and glucogenesis were dependent on
length of incubation and substrate concentration but also that these mechanisms were maintained over the course of incubation time chosen in
these experiments.
2.

Glucogenesis by inflammatory macrophage cell and sonicate
preparations

Table 14 presents the glucogenic response of macrophage whole
cells and sonicate preparations.

Macrophage sonicate preparations when

compared to intact cells demonstrated a significant increase in the rate
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FIGURE 7
GLUCOGENESIS BY INFLAMMATORY MACROPHAGES
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Macrophages were incubated in the presence of 50 mg of glycogen
and 3mM NaF. Each point represents the mean+ S.E. of at least four
experiments.

TABLE 14
GLUCOSE PRODUCTION BY INFLAMMATORY MACROPHAGE CELL AND SONICATE PREPARATIONS
No Additions

Glucogenesis - ,pg glucose/mg protein/hr
Glycogen 1 1C mg/ml) +
Glycogen(lO mg/ml)
NaF (3 mM)

Macrophage
Whole Cells

0.23 .:!:. 0.13 (3)

2.68.:!:. 0.35

(4)

12.30.:!:_1.75

(5)

Macrophage a.)
Sonicate

3.13.:!:. 0.97 (3)

15.56 .:!:. 2.49

( 3)

16.71 .:!:. 2.44

( 3)

a.)

Macrophages (20-50 x 106/ml) were sonicated for two minutes at 4°C in GFH, pH 7.4.

-.;J
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of glucose formation either in the absence or presence pf exogenous glycogen.

However, the addition of 50 mg of glycogen and 3mM NaF to mac-

rophage sonicate preparatiomresulted in a rate of glucose liberated of
16.71 ~ 2.4~ of glucose per mg protein per hour comparable to that
found in the intact cell preparation, i.e. 12.3 + 1. 75flg glucose per mg
protein per hour.

Furthermore, the glucogenic response of 15.56 ~ 2.49~g

glucose per mg protein per hour demonstrated by the addition of exogenous
glycogen alone to macrophage sonicates illustrates that the rate of glucose formation from sonicate glycogenolysis in the absence of any metabolic inhibitor is similar to the rate of glucogenesis by intact macrophages when substrate utilization is effectively inhibited by NaF.
3.

Effect of acid pH conditions on macrophage glucogenesis

In order to evaluate the possible role of macrophage acid-hydrolytic mechanisms on glycogenolysis and subsequent glucose formation,
exogenous glycogen was added to macrophage sonicate preparations under
neutral and acid pH conditions (Table 15).

Macrophage sonicates were

incubated for 180 minutes in a citrate phosphate buffer at either pH 7.0
or pH 5.0.

Glucose production by macrophage sonicates without the ad-

dition of exogenous glycogen demonstrated a probable endogenous glycogenolysis at both neutral and acid pH conditions.

The addition of exo-

genous glycogen to macrophage sonicates resulted in an augmentation of
macrophage glycogenolysis.

Moreover, macrophage sonicate glycogenolysis

and glucose formation in the presence of exogenous glycogen was further
augmented at pH 5.0 when compared to neutral pH conditions.
4.

Substrate and glycoside bond specificity of macrophage
glucogenesis

TABLE 15
THE EFFECT OF pH ON GLUCOSE PRODUCTION BY MACROPHAGE SONICATES
Macrophage Sonicate a.)

Glucogenesis- #g glucose/mg protein/hour
pH 7.0

+ 10 mg/ml Glycogen
- 10 mg/ml Glycogen

21.63 2:. 3. 70 b. )

8 . 50 2:. 1. 29

pH 5.0
32.72 2:. 5.02
9.02 2:. 1.97

a.)

Three ml of macrophage sonicates were incubated in citrate phosphate
buffer for 180 min.

b.)

Each value represents the mean+ standard error of the mean of 3
experiments.
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In view of the fact that o<-1,4 glucosidase prepominates as the
principal acid glucosidase present within the inflammatory macrophage,
substrate and glycoside bond specificity of macrophage glucogenesis was
investigated in intact macrophage preparations (Table 16).

Glycogen and

soluble starch containo<-1,4 and o(-1,6 glycoside bonds linking glucose
residues and both substrates can vary enormously in their particle size.
Dextrans are polysaccharides produced by the action of certain bacteria
(e.g. Leuconostoc mesenteroides) on sucrose and are composed almost entirely of glucose units joined by c<-1,6 glycosidic linkages.

Incubation

of intact inflammatory macrophages with either glycogen or starch resulted in comparable rate of glucogenesis, 12.3
mg protein per hour and 11.00

~ 0.31~

~ l.75~g

of glucose per

of glucose per mg protein per hour,

respectively, while the addition of two different molecular weight dextrans failed to liberate any significant amount of glucose.
5.

Effect of cyclic AMP on macrophage glucogenesis

In order to evaluate the potential role of a phosphorylytic mechanism mediated by glycogen phosphorylase

on the glucogenic mechanism,

experiments were performed to determine whether dibutyryl cyclic AMP
could influence macrophage glucose formation from exogenous glycogen.
Cyclic AMP and, in the presence of intact cells, the dibutyryl derivative are nucleotides known to activate phosphorylase kinase and glycogen phosphorylase (56).

Macrophages and PMNL were incubated under

identical conditions in the presence of 50 mg of glycogen, 3mM NaF and

lmM dibutyryl cyclic AMP for 180 minutes (Table 17).

The results in-

dicate that in the inflammatory macrophage, the addition of dbc AMP
produced a 63% increase in the rate of glucose formation in the presence

TABLE 16
SUBSTRATE AND GLYCOSIDE BOND SPECIFICITY OF MACROPHAGE GLUCOGENESIS a.)

Addition to
Incubation
Medium
a.)

Number of
Incubation
Samples

Glucogenesis

~g glucose/mg protein/hour

Glycogen

5

12.30.:!:_1.75

Starch

3

11.00.:!:. 0.31

Dextran
mw= 2 x 10 6

3

0.28 .:!:. 0.23

3

0.42.:!:. 0.31

Dextran
mw= 2 x 105

a. )

Two ml of macrophages were in cuba ted iri the presence of NaF ( 3 ml1) and
50 mg of carbohydrate in GFH for 180 min at 37°C.

co
0

TABLE 17
EFFECT OF CYCLIC AMP ON MACROPHAGE AND LEUKOCYTE GLUCOGENESIS a.)
Glucogenesis
Cell Population

.

-~g

glucose/mg protein/hour

-dbc AMP

+dbc AMP (1 rnM)

Inflammatory
Leukocyte

1.80 + 1.06

(4)

Inflammatory
Macrophage

12.20.:!:_1.75

(5)

a.)

b.)

1. 20 .:!:. 0 . 31 ( 3)
19.92.:!:. 0.90 (3)b.)

Two ml of cells were incubated with 10 mg/ml of glycogen and
3 rnM of NaF in a total volume of 3.0 ml for 180 min. at 37°C
with or withour 1 mM dbc AMP.
Significantly different from macrophages incubated without dbc
AMP (p<. 01).
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of exogenous glycogen.

In contrast, the inflammatory

P~

did not

exhibit any demonstrable change in their ability to liberate glucose
from a glycogen source in the whole cell system.

\

L

C~T~

V

DISCUSSION
The results of this study demonstrate a prominent glycogen
content in inflammatory macrophages originating from a 96 hour peritoneal exudate.

The inflammatory macrophage glycogen content of 9.55

~ 0.44.ug glycogen per 106 cells is not significantly different from
the glycogen content of 3 hour inflammatory leukocytes utilized in
this study and is also comparable to glycogen values reported for normal PMN leukocytes (43, 112).

Although a quantitative analysis of mac-

rophage glycogen content has not been previously reported, histological
studies have suggested glycogen to be a significant cytoplasmic constituent of mononuclear phagocytes.

Weiss and Fawcett (134) cultured

chicken buffy coat cells in autologous serum, allowing granulocytes and
platelets to disintegrate with continuing culture and leaving a uniform
population of adherent macrophages.

During the in vitro culture in-

cubations, macrophages were observed to markedly increase cytoplasmic
inclusions exhibiting a positive periodic acid-Schiff (PAS) reaction by
the ingestion of effete cells.

Wulff (142) investigated the glycogen

metabolism of developing macrophages and observed that, parallel to
maturation, an increase in PAS-positivity occurred.

Recently, Dvorak

et al. (38) demonstrated dense aggregations of glycogen within the
peripheral pseudopodia of migrating macrophages in capillary tube cultures.

Furthermore, in cultures where macrophage migration was
83
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inhibited by the presence of sensitized lymphocytes, glycogen-packed
pseudopodia were less prominent.

Interestingly, in the invertebrate

chiton Liolophura where the phagocytic cell represents the only.known
host defense mechanism to fore{gn body invasion or tissue injury, wandering macrophages have been collected from the hemolymph and have been
observed to coritain large aggregations of glycogen particles, at times
filling more than half of the cell's cytoplasmic space (71).

Therefore,

the present quantitative data discounts the previous notion that the
PMN leukocyte is the only white blood cell population to contain significant stores of glycogen (109, 125) and support~ the histological
evidence that macrophages can accumulate a large glycogen reserve.
The acquisition of glycogen by the macrophage at the inflammatory locus appears to occur by the active ingestion of cellular debris containing large deposits of glycogen.

Quantitative studies on

inflammatory leukocyte glycogen content have recently been conducted
on guinea pig blood and exudate leukocytes (111).

The glycogen content

of leukocytes entering the inflammatory site increased dramatically when
compared to control peripheral blood leukocytes.

The mean glycogen con-

tent of peripheral blood leukocytes of 6.5 ~ 1.3 mg of glycogen per 109
cells was elevated to 28.7 ~ 3.1 mg of glycogen per 109 cells in 24 hour
exudate leukocytes.

Indeed, the glycogen content of inflammatory leu-

kocytes was already significantly elevated after
induction of the inflammatory response.

4

hours following the

Examination of histological

evidence has repeatedly
suggested that exudate macrophages acquire gly,
cogen by the ingestion of leukocyte debris.

Wulff (141) demonstrated

that inflammatory macrophages progressively increased their glycogen
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content by the ingestion of neutrophil cytoplasmic fragments.

Rebuck

et al. (97)havefurther suggested that the acquisition of PAS- positive
neutrophilic debris by inflammatory macrophages was apparently dependent upon a functional macrophage carbohydrate metabolism.

The authors

proposed the concept that the depressed phagocytic capability of macrophages originating from insulin-deficient diabetics was due, in part,
to a failure of macrophages to increase their glycogen reserve.
The results of in vitro experiments in this study demonstrating
the uptake by inflammatory macrophages of exogenous glycogen clearly
arein agreement with the histological evidence

tha~

macrophages areca-

pable of ingesting glycogen at the inflammatory site.

Macrophages were

able to incorporate 14c-labelled glycogen into intracellular glycogen
stores, amounting to nearly 10% of the total glycogen content in a 15
minute incubation period.

Furthermore, inflammatory macrophages demon-

strated a profound increase in 14c-glycogen uptake at 37°C as compared
to incubation at 4°C, suggesting that the labelled glycogen was not
merely being adsorbed to the macrophage membrane during the incubation
interval.

Moreover, macrophages were able to maintain their glycogen

stores not only by the provision of

glucose to the incubation media

but also by the ingestion of exogenous glycogen in a glucose-free environment.

These results suggest that the macrophage at the inflam-

matory site is able to maintain functional integrity by the ingestion
of glycogen-containing cellular debris even though adequate substrate
supply may be interrupted.

'
A functional carbohydrate metabolism is mandatory for the provision
of cellular energy for the active endocytic process in phagocytic cells.
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The findings that, in peritoneal PMN leukocytes and macrophages, glycolytic inhibitors prevent phagocytosis, whereas inhibitors of respiration do not indicate that the energy requirement for particle uptake is ultimately derived from glycolysis (85, 106).

Pinocytosis

by peritoneal macrophages, in contrast, has been shown to be severely
depressed by inhibitors of oxidative phosphorylation and respiration

(16).

In vitro incubation under N2 atmospheric conditions did not in-

terfere with glycogen uptake by macrophages in a glucose-free media
when compared to macrophages incubated under air as the gas phase, suggesting that anaerobic glycolysis provided the necessary energy for
macrophage glycogen uptake.

Whether in vitro glycogen uptake was per-

formed by pinocytic or phagocytic mechanisms was not determined in
this study, although under in vivo conditions at the inflammatory site,
both endocytic mechanisms would be operative in the ingestion of soluble
glycogen or aggregates of the glycogen macromolecule.
The investigation into the alteration of macrophag~ glycogen
content during phagocytosis was an attempt to gain further insight into
the functional significance of the macrophage glycogen reserve.

Studies

examining the metabolic perturbations during phagocytosis by either leukocytes or macrophages have demonstrated a significant stimulation in
glucose utilization during the phagocytic event (23, 135).

The role of

leukocyte glycogen as an energy store to be utilized during phagocytosis
has been proposed by Scott (109).

Indeed, several studies have reported

leukocyte glyco£en levels to be depleted in vitro during phagocytosis

(6, 23, 120).

Inflammatory macrophages incubated in the presence of

latex particles were observed to significantly accelerate glycogenolysis

in the absence of glucose when compared to non-phagocytizing controls.
Thus the evidence suggests that the inflammatory macrophage glycogen
reserve can also be called upon to provide for the augmented glucose
demands during phagocytosis.
Incubation for
half of the

ma~rophage

60 minutes in a glucose-free media mobilized
glycogen supply, however, incubation for longer

intervals did not further deplete endogenous glycogen stores.

The in-

ability to mobilize the entire glycogen reserve in macrophages has not
been determined, although studies involved in the molecular structure
of glycogen have revealed that apparently only 60% of the total glucose
residues forming the outer linear chains of the .glycogen molecule are
readily accessible to the action of phosphorylase (115).

Additional

support for the role of macrophage glycogen in maintaining active
phagocytic mechanisms was provided utilizing glycogen-depleted macrophages.

The results in this in vitro study demonstrate that the addition

of exogenous glycogen in a glucose-free media to macrophages,whose energy
stores have been depleted did not increase macrophage glycogen levels to
initial control values, although glycogen-depleted macrophages readily
synthesized glycogen when extracellular glucose was available.

The de-

pression of macrophage ·phagocytic ability in glycogen-depleted cells
was further supported by the fact that the uptake of 14c-labelled glycogen by glycogen-depleted macrophages in a glucose-free media was depressed nearly 50% when compared to glycogen-laden macrophages.

These

results suggest that the depletion of macrophage carbohydrate reserve
may significantly reduce the capacity of inflammatory macrophages to participate in the inflammatory reaction by depressing macrophage function
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when glucose is not readily available.
The in vitro incorporation of 14c-glucose into macrophage glycogen offers some insight into the changing balance of synthesis at
different glycogen loads.

The rate of glycogen synthesis in inflam-

matory macrophages partially depleted of their glycogen reserve was accelerated more than three-fold when compared to glycogen-laden cells
when incubated in the presence of 14c-U-glucose.

These results were

consistent with similar observations made in the PMN leukocyte (109,
111) and in glycogen-depleted human cytotrophoblastic cells -- a cell
line that relies heavily on glycogen as an energy source (89).

The

in vitro results in the present study raise the possibility that a relationship exists between the initial glycogen content of macrophages
and the rate of incorporation of glucose into glycogen.

In skeletal

muscle (75) and liver (35), glycogen decreases its own synthesis nonhormonally by inhibition of glY,cogen synthetase D phosphatase, the enzyme that converts synthetase D to synthetase I.
Wang et al. (132) that glycogen

reple~ion

It was suggested by

of PMN leukocytes is as-

sociated with a rapid change from the D-form of the enzyme to the I-form
with a small change in total enzyme activity.

More recently, Scott and

Cooper (111) observed a significant elevation in glycogen synthetase activity in exudate leukocytes when compared to blood leukocytes and attributed the change in enzyme activity to an increase in the glucose-6phosphate dependent (D) form of the enzyme.
The present results clearly demonstrate the activity of UDP
glucose-glucan glucosyl transferase (i.e. glycogen synthetase) in macrophage sonicates.

Macrophage glycogen synthetase activity independent of

glucose-6-phosphate (I-form) was equal to 5.9% of the total (I and D)
activity.

Furthermore, when macrophages were incubated for 2 hours in

a glucose-free media, the I activity increased to nearly 11%.

This two

fold increase in I activity suggests a decreased inhibitory effect of
glycogen on the synthetase phosphatase.
D to I

conversi~n

A similar glycogen synthetase

has recently been reported in the human PMN leukocyte

(132) and also in human lymphocytes {57).

Depletion of macrophage gly-

cogen content for 2 hours significantly increased glycogen synthetase
activity not only in the glucose-6-phosphate independent or I form but
also in the dependent or D form.

In liver, the activation of glycogen

synthetase (D to I conversion) involves a dephosphorylation catalyzed by
a specific phosphatase, thus the activity of glycogen synthetase, like
that of phosphorylase, appears to depend on a finely tuned regulatory
mechanism between the activities of kinases and phosphatases.

The pre-

sent evidence suggests such a regulatory mechanism for glycogen synthesis
is operational within the inflammatory macrophage and furthermore, that
alterations in glycogen levels within the cell will exert a profound influence on the macrophage glycogen synthetic machinery.
Insulin, a potent stimulator of glycogen synthetic mechanisms
in adipose tissue and skeletal muscle, failed to increase l4c-glucose incorporation into macrophage glycogen at an insulin concentration of 200fU/ml.
These results support the conclusions of Esmann. ( 44) who also failed to
find any in vitro effect of insulin at physiological concentrations on
glucose transport or glycogen synthesis in the PMNL, although prolonged
incubation and high insulin concentration (lU/ml) did result in a nonspecific increase in glucose transport.

However, the addition of 1%
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albumin to the incubation media significantly doubled the in vitro incorporation of 14c-glucose into macrophage glycogen in a
cubation period.

60 minute in-

Cohn and Parks (24) have investigated the pinocytosis-

inducing effect of a number of molecular species and have found certain
proteins, in particular plasma albumin, to be potent stimulators of vesicle formation in macrophages.

The addition of insulin to the media

containing albumin did not further enhance 14 C-glucose incorporation into
macrophage glycogen.

Thus the present results suggest that stimulation

of macrophage pinocytosis results in an increased transport of extracellular glucose, offering endocytosis as a mechanism facilitating glycogen
synthesis by increasing the incorporation of available extracellular
glucose.
The demonstration of macrophage phosphorylase activity indicates
that, in view of the broad variation in macrophage energy demands at the
inflammatory site, glycogen mobilization is controlled by a finely balanced
regulatory mechanism.

Rapid glycogenolysis is accomplished'bY the acti-

vation of glycogen phosphorylase and is controlled by a complex cascade
of phosphorylation-dephosphorylation reactions.

Green and Cori (Sl) were

the first to isolate rabbit skeletal muscle phosphorylase and found
readily interconvertible active and inactive forms.

Sutherland et al.

(123) characterized the two forms of phosphorylase in liver homogenates

and demonstrated that the conversion of the inactive to active form required the presence of ATP, Mg++ and the enzyme phosphorylase b kinase.
Distinct differences exist in the phosphorylase activity from these two
tissues.

The inactive skeletal muscle enzyme becomes active in the

pre-

sence of AMP, while the active form has an activity independent of AMP.
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In contrast, the inactive liver enzyme demonstrates little activity
even in the presence of the nucleotide, whereas the active form is
stimulated only 40% by AMP.

Detailed studies on the protein kinases

responsible for the phosphorylation of muscle phosphorylase b has revealed that they also occur as active and inactive forms.

Studies by

Krebs et al. (7·4) have shown that the conversion of the inactive to
active form of phosphorylase b kinase takes place on incubation with
ATP and Mg++, resulting in the phosphorylation of the inactive form.
Maddaiah and Madsen (79) have demonstrated that 60% of resting liver
phosphorylase activity is in the active form while resting skeletal
muscle phosphorylase activity is predominantly in the b or inactive
form (72).

The levels of cofactors and substrates in the cell have been

shown to influence the interconversion reactions of phosphorylase and
synthetase.

Krebs et al. (74) have demonstrated that elevated glycogen

levels stimulate the phosphorylase b to a conversion and also the activation of phosphorylase b kinase whereas, increased glycogen . levels inhibited the synthetase D to I conversion (128).
Determination of leukocyte phosphorylase activity demonstrated
a behavior similar to that found in liver in that it was possible to
activate leukocyte phosphorylase activity in vitro by glucagon (137).
Recently, Yunis and Arimura (143) examined the properties of glycogen
phosphorylase in rat chloroma cells, a tumor composed entirely of immature granulocytes, and noticed that leukocyte phosphorylase exhibited
considerable activity in the absence of AMP and thus resembled liver
phosphorylase.

The present results of phosphorylase assays in inflam-

matory macrophage extracts indicate that a significantly large fraction
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of the total phosphorylase activity exists in the active form (73%),
thus, in this one respect, macrophage phosphorylase activity resembled
leukocyte and liver phosphorylase activity.

Total phosphorylase ac-

tivity did not significantly change during a l hour period of glycogenolysis in a glucose-free media, however, phosphorylase activity increased significantly 15 minutes following the addition of exogenous
~lycogen

when compared to initial control values, again comparable to

liver phosphorylase.

Conversion of inactive to active liver phosphory-

lase has been shown to occur readily in the presence of Mg++ and ATP
(94).

Macrophage active phosphorylase activity was markedly enhanced

in macrophage sonicates incubated in the presence of O.lM Mg++_ATP following the partial inactivation of the active form by a 30 minute preincubation.

The results suggest that the Mg++_ATP stimulation of macro-

phage active phosphorylase activity is similar to those mechanisms described in liver and muscle.

The activation of this protein kinase in

these tissues by Mg++_ATP is strongly stimulated by cyclic AMP.

The

now classic studies by Sutherland and Rall (122) on the physiology of
cyclic AMP have demonstrated that phosphorylase activation via the
adenyl cyclase system provides rapid glycogenolysis and increased glucose output by liver preparations.
et al.

(10~

In support of this concept, Reik

have localized a hormone-sensitive adenyl cyclase activity

in reticuloendothelial cells of the liver utilizing both cytochemical
and biochemical techniques.

In addition, alveolar macrophages have been

found to exhibit a significant increase in the intracellular level of
cyclic AMP and thus suggesting a link between particle uptake and the
initiation of metabolic events requiring the accelerated expenditure
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of energy in the form of glycogenolysis (114).

Thus the glycogen mo-

bilization via phosphorylase by the, inflammatory macrophage may also
respond in a similar fashion via a hormone-sensitive adenyl cyclase mechanism that would function in rapidly providing glucose to meet the
substrate demand of the macrophage at the inflammatory locus.
The pre'sence of an acid {)(,-glucosidase in inflammatory macrophages provides an alternate mechanism for the degradation of the glycogen molecule.

This is the only known lysosomal enzyme capable of de-

grading glycogen.

Jeffrey et al. (64) have recently purified an

~

glucosidase from the lysosomal fraction of rat liver homogenates and
have demonstrated that the enzyme had both o(-1,4 and o(.-1,6 glucosidase
activity.

Hers (58) initially demonstrated the deficiency of a lyso-

somal acid maltose,

c<-1,4 glucosidase, in the livers of patients with

Pompe's disease (Type II glycogenesis), a fatal disorder characterized
by the accumulation of glycogen in the heart, skeletal muscle, brain,
liver and kidney.

Williams (136) measured <::>(-glucosidase a'ctivity in

human PMN leukocytes from normal subjects and from patients with Type
II glycogenesis and demonstrated that leukocytes from patients with
Pompe's disease display approximately one half the activity of the
normal controls.
Hsia et al. (61) have characterized an o<-glucosidase in human
PMN leukocytes and were able to show activity with maltose as a substrate;
however, no

~-1,6

as substrate.

glucosidase activity was observed utilizing isomaltose

The results of the present study utilizing the macrophage

indicate a prominent o(,-1,4 glucosidase activity measured at pH 4.0 with
maltose as substrate.

Furthermore, that only

~-1,4

glucosidase activity

was manifest in macrophage sonicates and negligible

~-+,6

glucosidase

activity was observed is comparable to the results found in the PMN
leukocyte.

The determination of a

4.0

pH optimum for macrophage

o<-

1,4 glucosidase activity is in agreement with results described for
liver o( -1,4 glucosidase (58) and in PMN leukocytes (136) and strongly
suggests a probable lysosomal origin within the macrophage for the acid
glucosidase activity.

Therefore, the identification within macrophages

of a hydrolytic degradative mechanism for glycogen indicates that subsequent to the discharge of lysosomal hydrolases into a glycogen-containing phagocytic vacuole, lysosomal glucosidase could readily attack
the outer linear branches of the glycogen molecule providing available
free glucose for macrophage functional energy demands.
In view of the fact that glucose-6-phosphatase provides the
final enzymatic link in the provision of free extracellular glucose
from the glycogenolytic sequence, particular interest is raised in this
study when glucose-6-phosphatase activity was observed in maGrophage
sonicates.

It is generally accepted that glucose-6-phosphatase acti-

vity is manifested predominantly in those organs which function in the
regulation of blood glucose.

Thus, Hers and DeDuve (59) found glucose-

6-phosphatase activity greatest in liver, kidney and in small intestine.
Although no glucose-6-phosphatase activity has been reported biochemically in other white blood cells (61, 109), the blood platelet however,
does contain measurable amounts of glucose-6-phosphatase (52).

Recent

histochemical evidence revealed that glucose-6-phosphatase activity was
localized in rat and mouse RES cells, in particular, alveolar macrophages and Kupffer cells of the liver (104).

The present evidence
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supplies the quantitative data in support of the histochemical demonstration of glucose-6-phosphatase activity in macrophages.
The functional significance of glucose-6-phosphatase in RES
cells has not been previously investigated.

The active phosphorylytic

attack of macrophage glycogen by phosphorylase would result in the formation of glucase-6-phosphate which predominantly would be further metabolized via glycolytic or hexose monophosphate shunt pathways to
meet macrophage energy demands.

However, the presence of glucose-6-

phosphatase in inflammatory macrophages provides a third alternative to
the metabolism of

glucose-6-phosph~te,

whereby the hydrolytic attack on

the molecule would result in the formation of free glucose.

Therefore,

the macrophage at the inflammatory site is equipped with the full complement of glucogenic enzymes and is capable enzymatically of supplying
glucose to its extracellular environment.

Thus the present characteri-

zation of glycogenolytic and glucogenic enzymes within the inflammatory
macrophage reveals an additional trophic functional role for,the large
carbohydrate supply ingested and stored by the inflammatory macrophages.
The process of glucogenesis, i.e. the liberation of glucose,
was demonstrated in vitro in the peritoneal exudate cells and significant
increases were observed in macrophages in the presence of glycogen and
NaF, a glycolytic inhibitor.

In contrast, neither inflammatory PMN leu-

kocytes nor unstimulated peritoneal mononuclear cells responded by augmented glucose liberation when exogenous glycogen and the glycolytic inhibitor were added.

The use of a glycolytic inhibitor in vitro to ex-

aggerate the glucogenic response by inflammatory macrophages may mimic
the in vivo situation whereby the glycolytic pathway is depressed by a

decrease in intracellular pH initiated by the release of acid hydrolases
into the cytosol.

In support of this concept, Halpern et al. (53) re-

cently compared the rate of glycolysis in leukocytes incubated in media
of low pH values and found that the inhibition of glycolysis was due to
an inhibition of the activity of phosphofructokinase, a key regulatory
enzyme of the glycolytic pathway.
Recent studies by Cohn and Ehrenreich (20) relevant to the mechanisms involved in the uptake of digestible and nondigestible carbohydrates by cultured macrophages have demonstrated that large carbohydrate molecules are pinocytized and stored within lysosomal associated
vacuoles.
with

Intralysosomal hydrolysis of carbohydrates then takes place

the formation of utilizable monosaccharides which escape from

the vacuole.

It appears reasonable to speculate that such a mechanism

is employed following the ingestion of glycogen-contai~ing debris from
the inflammatory environment.

The resulting release of glucose from the

phagocytic vacuole would then be either further metabolized ·or liberated
from the macrophage and utilized by ongoing reparative processes at the
inflammatory site.
In an attempt to extend these

observation~macrophage

sonicate

preparations were employed to investigate the hydrolytic degradation of
glycogen by inflammatory macrophages.

The rate of glucogenesis in macro-

phage whole cells was found to be comparable to the rate of glycogenolysis
in macrophage sonicates indicating that macrophage lysosomal glucosidase
released upon sonication could account for the observed rate of glucose
liberation in the intact macrophage when glucose utilization was depressed.

Glycogen and starch are composed of

D-glucose units linked by
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o{-1,4 and o(-1,6 glycoside bonds whereas dextrans are\polysaccharides
composed entirely of glucose units joined by

~-1,6

glycoside bonds.

A comparison of the hydrolytic action by macrophage sonicates on large
molecular weight polysaccharides revealed that glucogenic activity was
manifest only in the presence of carbohydrates where
bonds are prominent.

~-1,4

glycoside

Thus these present studies concur with the enzyma-

tic demonstration that c<-1,6 glucosidase is not active within the macrophage lysosome.

Although

glucosi~ase

activity in macrophage subcellu-

lar compartments by fractionation techniques was not determined in this
study, the probable lysosomal origin of the

hydr~lytic

activity on the

glycogen molecule was inferred when exogenously added glycogen was more
rapidly hydrolyzed to glucose by macrophage sonicates under acid pH
conditions favored by lysosomal hydrolases.
An important functional role for phosphorylase as a degradative
process involved in macrophage glycogen breakdown was illustrated by the
in vitro addition of dibutryl cyclic AMP to macrophages ingesting exogenous glycogen.

Macrophage glycogenolytic and glucogenic mechanisms

in intact cells responded to the addition of dibutyryl cyclic AMP by a
notable increase in the glucose liberated from intact inflammatory macrophages.

It is reasonable to assume that dibutyryl cyclic AMP accele-

rated intracellular glycogenolysis by stimulating the activation of macrophage phosphorylase and, coupled with the hydrolytic action of glucose6-phosphatase, augmented the liberation of glucose supplied by the acid
hydrolytic mechanism.

Park et al. (88) postulated that adenyl cyclase

I

activation during phagocytosis may be the initiating event triggering
subsequent metabolic alterations during phagocytosis, thus emphasizing a
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role for phosphorylase activation and the ensuing glycogenolysis in the
energetics of particle engulfment within phagocytic cells.

The present

study suggests that the degradative pathways involved in glycogenolysis
within the macrophage include both hydrolytic and phosphorylytic mechanisms and furthermore, that both mechanisms may be operative in supporting macrophage glucogenesis.
The present studies have demonstrated that the inflammatory macrophage is equipped to harvest a prominent carbohydrate reservoir by the
ingestion of exogenous glycogen as well as by glycogen synthetic enzymes.
Furthermore, the dynamic state of macrophage glycogen metabolism has
been evaluated by the demonstration of a complex glycogen degradative
apparatus, capable of responding to regulatory control mechanisms, to
provide additional glucose to meet a wide spectrum of macrophage energy
demands.

The studies illustrating the effect of glycogen depletion on

the phagocytic ability of the macrophage

emphasizes that further in-

vestigation is needed to adequately clarify the physiological role of
glycogen metabolism within the phagocytic cell.

The demonstration of a

glucogenic capacity within the inflammatory macrophage adds a new dimension to macrophage function suggesting that an important nutrient role
may be served by the macrophage at the inflammatory site in the form of
glucose provision to assist the.reparative processes of tissue healing
mechanisms.

CHAPTER VI
SUMMARY

l. , Caseinate-induced 3 hour exudates yielded 6 to 7 x 106
cells with greater than 90% of the cell population examined being PMNL.
The 96 hour inflammatory exudate produced 2 to 3 x 108 cells per rat
with macrophages comprising 85 to 90% of the cell population from the
peritoneum.
2.

The 96 hour inflammatory macrophage demonstrated a prominent

glycogen content of 11.79 ~ l.5~;g glycogen per 106 cells or 110.3 ~
l2.&~g

glycogen per mg of cell protein that was comparable to the glyco-

gen content of the inflammatory PMNL.
3.

Both PMNL and macrophages exhibited a labile intracellular

glycogen pool that was decreased to approximately 50% of control values
by incubation in glucose-free Hank's for 60 minutes.

Furthermore, when

macrophages were incubated in the presence of latex particles in a glucose-free medium, the glycogen content of phagocytizing macrophages was
further diminished when compared to non-phagocytizing macrophages.

4.

Inflammatory macrophages incubated in the presence of

either 10 mM glucose or 10 mg/ml of exogenous glycogen maintained their
large glycogen reserve during a 60 minute incubation interval.

99

100

5.

Macrophage glycogen resynthesis from glucose was stimulated

by preincubation for 2 hours in a glucose-free medium.

However, the

addition of exogenous glycogen to glycogen depleted rnacrophages did not
result in an elevation of macrophage glycogen content in glycogen depleted cells.

6.

Glycogen synthesis in glycogen depleted macrophages from

14c-U-glucose was accelerated three-fold when compared to 14c-U-glucose
incorporation into glycogen from glycogen laden macrophages.
7.

Inflammatory macrophages incubated in the presence of 1%

albumin doubled their incorporation of 14c-U-glucose into macrophage
glycogen when compared to cells incubated without the pinocytic activator.

20~U/rnl of insulin did not enhance the incorporation of 14-c-

U-glucose into macrophage glycogen.

8.

Exogenous 14C-labelled glycogen was readily incorporated

into the .macrophage glycogen pool.

In contrast, incorporation of 14c-

glycogen by glycogen depleted macrophages was markedly depressed.

9.

Inflammatory macrophages exhibited glycogen phosphorylase

activity that was significantly increased in the presence of exogenous
glycogen.

Macrophage active phosphorylase activity amounted to 73% of

the total phosphorylase activity and the introduction of 0.1 M Mg++_
ATP to macrophage sonicates resulted in a nearly complete conversion
of macrophage phosphorylase activity to the active form.
10.

Inflammatory macrophages demonstrated

considerable~-1,4
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glucosidase activity that manifested its greatest acti~ity at pH 4.0.
In contrast, macrophages displayed no .o\-1,6 glucosidase activity.
11.

Macrophage glycogen synthetase was found to exist in

two forms, a glucose-6-phosphate dependent or D-form and a glucose-6phosphate independent or I-form.

The I-form amounted to approximately

6% of the total glycogen synthetase activity.
12.

Glycogen depletion in inflammatory macrophages resulted

in a dramatic increase in both the I and D-forms of glycogen synthetase.
Glycogen depletion produced an 83% increase in the I-form as compared
to glycogen laden macrophages.
13.

Inflammatory macrophages displayed a significant glucose-

6-phosphatase activity suggesting the enzymatic ability to liberate
free glucose from intracellular glycogenolytic mechanisms.
14.

Glucogenesis, i.e., glucose liberation into the incu-

bation medium was demonstrated by 96 hour inflammatory macrophages
in the presence of NaF and exogenous glycogen.

Macrophage glucogenesis

was greater at pH 5.0 than at pH 1.0.
15.

Macrophage glucogenesis was marked in the presence of

either exogenous glycogen or soluble starch while the addition of
various molecular weight dextrans was ineffective in liberating
glucose by macrophages.
16.

Glucogenesis in both intact macrophages and sonicate

preparations was augmented by dbc AMP while PMN leukocyte glucogenesis
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was not affected by dbc AMP.
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